Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 20619. Отображено 100.
16-01-1997 дата публикации

УСТРОЙСТВО ДЛЯ ОХЛАЖДЕНИЯ НИТРОЗНОГО ГАЗА

Номер: RU0000003399U1
Автор: Губа Наталья Борисовна[UA], Зарубин Владимир Михайлович[UA], Перепадья Николай Петрович[UA], Рябчиков Александр Алексеевич[UA]
Принадлежит: Малое коллективное предприятие "Стикис"

Устройство для охлаждения нитрозного газа, состоящее из двух последовательно включенных теплообменников, причем второй по ходу газа выполнен из нержавеющей стали, отличающееся тем, что первый по ходу газа теплообменник изготавливается из титановых сплавов. (19) RU (11) (13) 3 399 U1 (51) МПК B01J 19/02 (1995.01) C01B 21/40 (1995.01) РОССИЙСКОЕ АГЕНТСТВО ПО ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К СВИДЕТЕЛЬСТВУ (21), (22) Заявка: 95111949/25, 25.07.1995 (46) Опубликовано: 16.01.1997 (71) Заявитель(и): Малое коллективное предприятие "Стикис" (UA) R U 3 3 9 9 (57) Формула полезной модели Устройство для охлаждения нитрозного газа, состоящее из двух последовательно включенных теплообменников, причем второй по ходу газа выполнен из нержавеющей стали, отличающееся тем, что первый по ходу газа теплообменник изготавливается из титановых сплавов. Ñòðàíèöà: 1 U 1 U 1 (54) УСТРОЙСТВО ДЛЯ ОХЛАЖДЕНИЯ НИТРОЗНОГО ГАЗА 3 3 9 9 (73) Патентообладатель(и): Малое коллективное предприятие "Стикис" (UA) R U (72) Автор(ы): Рябчиков Александр Алексеевич[UA], Перепадья Николай Петрович[UA], Зарубин Владимир Михайлович[UA], Губа Наталья Борисовна[UA] RU 3 399 U1 RU 3 399 U1 RU 3 399 U1

Подробнее
Номер записи: 1
16-04-1998 дата публикации

КАМЕРА ПОДОГРЕВА ХВОСТОВЫХ ГАЗОВ

Номер: RU0000006389U1
Автор: Лашин Владимир Иванович[UA], Петренко Георгий Константинович[UA], Рябчиков Александр Алексеевич[UA]
Принадлежит: Малое коллективное предприятие "Стикис"

Камера подогрева хвостовых газов, содержащая корпус с штуцером, внутри которого находится жаровая труба с многогорелочными регистрами и смесителем, и присоединенной на фланцах к корпусу хвостовую часть с горелками, разделительную мембрану, отличающаяся тем, что между хвостовой частью эллипсообразной формы и фланцем вставляется цилиндрическая обечайка с штуцером подвода первичного воздуха, причем сами горелки удлиняются на длину вставляемой цилиндрической обечайки, а разделительная мембрана крепится жестко к регистрам и вплотную подходит к корпусу. (19) RU (11) (13) 6 389 U1 (51) МПК C01B 21/40 (1995.01) РОССИЙСКОЕ АГЕНТСТВО ПО ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К СВИДЕТЕЛЬСТВУ (21), (22) Заявка: 96105791/20, 26.03.1996 (46) Опубликовано: 16.04.1998 (71) Заявитель(и): Малое коллективное предприятие "Стикис" (UA) (73) Патентообладатель(и): Малое коллективное предприятие "Стикис" (UA) U 1 6 3 8 9 R U Ñòðàíèöà: 1 U 1 (57) Формула полезной модели Камера подогрева хвостовых газов, содержащая корпус с штуцером, внутри которого находится жаровая труба с многогорелочными регистрами и смесителем, и присоединенной на фланцах к корпусу хвостовую часть с горелками, разделительную мембрану, отличающаяся тем, что между хвостовой частью эллипсообразной формы и фланцем вставляется цилиндрическая обечайка с штуцером подвода первичного воздуха, причем сами горелки удлиняются на длину вставляемой цилиндрической обечайки, а разделительная мембрана крепится жестко к регистрам и вплотную подходит к корпусу. 6 3 8 9 (54) КАМЕРА ПОДОГРЕВА ХВОСТОВЫХ ГАЗОВ R U (72) Автор(ы): Петренко Георгий Константинович[UA], Лашин Владимир Иванович[UA], Рябчиков Александр Алексеевич[UA] U 1 U 1 6 3 8 9 6 3 8 9 R U R U Ñòðàíèöà: 2 RU 6 389 U1 RU 6 389 U1 RU 6 389 U1 RU 6 389 U1

Подробнее
Номер записи: 2
20-09-2004 дата публикации

УСТАНОВКА ДЛЯ ПРОВЕДЕНИЯ СПОСОБА ВЫДЕЛЕНИЯ ТРИФТОРИДА АЗОТА

Номер: RU0000040632U1
Автор: Алексеев Ю.И., Асович В.С., Пашкевич Д.С.
Принадлежит: Общество с ограниченной ответственностью "НьюКем"

1. Установка для выделения трифторида азота, включающая колонну ректификации, дефлегматор и кипятильник, отличающаяся тем, что колонна заполнена насадкой эффективностью не менее 200 теоретических тарелок с вводом для реакционной смеси, расположенным над 80-90 теоретической тарелкой от верха, выводом для смеси тетрафторметана и трифторида азота, расположенным выше 6 теоретической тарелки от верха, выводом для низкокипящих компонентов из верхней части дефлегматора и с выводом трифторида азота из кипятильника. 2. Установка по п.1, отличающаяся тем, что состоит из двух последовательно соединенных секций. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 40 632 (13) U1 (51) МПК C01B 21/08 (2000.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2004103357/22 , 02.02.2004 (24) Дата начала отсчета срока действия патента: 02.02.2004 (46) Опубликовано: 20.09.2004 (73) Патентообладатель(и): Общество с ограниченной ответственностью "НьюКем" (RU) U 1 4 0 6 3 2 R U Ñòðàíèöà: 1 U 1 Формула полезной модели 1. Установка для выделения трифторида азота, включающая колонну ректификации, дефлегматор и кипятильник, отличающаяся тем, что колонна заполнена насадкой эффективностью не менее 200 теоретических тарелок с вводом для реакционной смеси, расположенным над 80-90 теоретической тарелкой от верха, выводом для смеси тетрафторметана и трифторида азота, расположенным выше 6 теоретической тарелки от верха, выводом для низкокипящих компонентов из верхней части дефлегматора и с выводом трифторида азота из кипятильника. 2. Установка по п.1, отличающаяся тем, что состоит из двух последовательно соединенных секций. 4 0 6 3 2 (54) УСТАНОВКА ДЛЯ ПРОВЕДЕНИЯ СПОСОБА ВЫДЕЛЕНИЯ ТРИФТОРИДА АЗОТА R U Адрес для переписки: 192242, Санкт-Петербург, а/я 77, Ю.И. Алексееву (72) Автор(ы): Алексеев Ю.И. (RU) , Асович В.С. (RU) , Пашкевич Д.С. (RU) U 1 U 1 4 0 6 3 2 4 0 6 3 2 R U R U Ñòðàíèöà: 2 RU 5 10 15 20 25 30 35 40 45 50 40 632 ...

Подробнее
Номер записи: 3
10-01-2007 дата публикации

КАТАЛИТИЧЕСКАЯ СИСТЕМА ДЛЯ КОНВЕРСИИ АММИАКА

Номер: RU0000060074U1
Автор: Бокий Владимир Андреевич, Звягин Владимир Николаевич, Кедров Виктор Викторович, Струков Геннадий Васильевич, Хальзов Павел Иванович
Принадлежит: Общество с ограниченной ответственностью "Термокем"

1. Каталитическая система для конверсии аммиака, состоящая из платиноидных сеток и тканых сеток из неплатиноидных сплавов, отличающаяся тем, что платиноидные сетки тканой или вязаной структуры, тканые неплатиноидные сетки снабжены активной фазой - платиной, а соотношение количества платиноидных и неплатиноидных сеток составляет от 5:1 до 1:1. 2. Каталитическая система по п.1, отличающаяся тем, что в качестве тканых сеток из неплатиноидных сплавов используют сетки из термостойких сталей. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 60 074 (13) U1 (51) МПК C01B 21/26 (2006.01) B01J 23/42 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2006121895/22 , 21.06.2006 (24) Дата начала отсчета срока действия патента: 21.06.2006 (45) Опубликовано: 10.01.2007 (73) Патентообладатель(и): Общество с ограниченной ответственностью "Термокем" (RU) U 1 6 0 0 7 4 R U Ñòðàíèöà: 1 U 1 Формула полезной модели 1. Каталитическая система для конверсии аммиака, состоящая из платиноидных сеток и тканых сеток из неплатиноидных сплавов, отличающаяся тем, что платиноидные сетки тканой или вязаной структуры, тканые неплатиноидные сетки снабжены активной фазой - платиной, а соотношение количества платиноидных и неплатиноидных сеток составляет от 5:1 до 1:1. 2. Каталитическая система по п.1, отличающаяся тем, что в качестве тканых сеток из неплатиноидных сплавов используют сетки из термостойких сталей. 6 0 0 7 4 (54) КАТАЛИТИЧЕСКАЯ СИСТЕМА ДЛЯ КОНВЕРСИИ АММИАКА R U Адрес для переписки: 141600, Московская обл., г.Клин, ул. Мира, 14, кв.2,пат.пов. Т.А. Козловой, рег.№ 451 (72) Автор(ы): Бокий Владимир Андреевич (RU), Хальзов Павел Иванович (RU), Звягин Владимир Николаевич (RU), Кедров Виктор Викторович (RU), Струков Геннадий Васильевич (RU) RU 5 10 15 20 25 30 35 40 45 50 60 074 U1 Полезная модель относится к устройствам конверсии аммиака на каталитических системах и может быть использована, преимущественно, в ...

Подробнее
Номер записи: 4
20-08-2008 дата публикации

УСТАНОВКА ДЛЯ ОЧИСТКИ ДЫМОВЫХ ГАЗОВ, ОТХОДЯЩИХ ОТ КОКСОВОЙ ПЕЧИ

Номер: RU0000075646U1
Автор: Данилин Евгений Алексеевич, Лобов Александр Александрович
Принадлежит: Данилин Евгений Алексеевич, Лобов Александр Александрович

Установка для очистки дымовых газов, отходящих от коксовой печи, содержащая, по меньшей мере, одну коксовую печь, соединенную с дымовой трубой посредством борова, снабженного шибером, который размещен в зоне примыкания борова к дымовой трубе, контур очистки дымовых газов, включающий котел-утилизатор, дымосос с направляющим аппаратом и регулирующий клапан, размещенный в зоне выхода указанного контура, примыкающего к дымовой трубе, при этом вход указанного контура очистки дымовых газов подключен к борову в зоне примыкания борова к коксовой печи, отличающаяся тем, что установка снабжена газоходом, который связывает выход контура очистки дымовых газов с боровом, при этом вход газохода связан с указанным контуром перед регулирующим клапаном по ходу движения дымовых газов, а выход газохода связан с боровом в зоне примыкания борова к дымовой трубе перед шибером по ходу движения дымовых газов, при этом газоход снабжен регулятором потока дымовых газов. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 75 646 (13) U1 (51) МПК C01B 21/00 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2008107547/22 , 27.02.2008 (24) Дата начала отсчета срока действия патента: 27.02.2008 (72) Автор(ы): Данилин Евгений Алексеевич (UA), Лобов Александр Александрович (UA) (45) Опубликовано: 20.08.2008 7 5 6 4 6 R U Формула полезной модели Установка для очистки дымовых газов, отходящих от коксовой печи, содержащая, по меньшей мере, одну коксовую печь, соединенную с дымовой трубой посредством борова, снабженного шибером, который размещен в зоне примыкания борова к дымовой трубе, контур очистки дымовых газов, включающий котел-утилизатор, дымосос с направляющим аппаратом и регулирующий клапан, размещенный в зоне выхода указанного контура, примыкающего к дымовой трубе, при этом вход указанного контура очистки дымовых газов подключен к борову в зоне примыкания борова к коксовой печи, отличающаяся тем, что установка ...

Подробнее
Номер записи: 5
10-12-2008 дата публикации

УСТРОЙСТВО ДЛЯ УДАЛЕНИЯ NО

Номер: RU0000078787U1
Автор: Рябчиков Александр Алексеевич, Рябчиков Вадим Александрович
Принадлежит: Рябчиков Александр Алексеевич, Рябчиков Вадим Александрович

Устройство для удаления NO в производстве азотной кислоты, которое включает в себя катализатор, отличающееся тем, что катализатор размещен после газовой турбины в самом газоходе или в середине входной газовой камеры котла-утилизатора, установленного после газовой турбины. (19) РОССИЙСКАЯ ФЕДЕРАЦИЯ RU (11) 78 787 (13) U1 (51) МПК C01B 21/26 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2008127008/22 , 02.07.2008 (24) Дата начала отсчета срока действия патента: 02.07.2008 (45) Опубликовано: 10.12.2008 (73) Патентообладатель(и): Рябчиков Вадим Александрович (UA) , Рябчиков Александр Алексеевич (UA) 2 Формула полезной модели Устройство для удаления N2O в производстве азотной кислоты, которое включает в себя катализатор, отличающееся тем, что катализатор размещен после газовой турбины в самом газоходе или в середине входной газовой камеры котла-утилизатора, установленного после газовой турбины. 7 8 7 8 7 (54) УСТРОЙСТВО ДЛЯ УДАЛЕНИЯ N О R U Адрес для переписки: 84646, Украина, Донецкая обл., г. Горловка, пр-кт Победы, 72/125, В.А. Рябчикову (72) Автор(ы): Рябчиков Вадим Александрович (UA) , Рябчиков Александр Алексеевич (UA) R U 7 8 7 8 7 U 1 U 1 Ñòðàíèöà: 1 RU 5 10 15 20 25 30 35 40 78 787 U1 Полезная модель относится к производству азотной кислоты и касается удаления полученного по не целевой реакции N20 при окислении (сжигании) аммиака. Известно устройство для удаления N20 в производстве азотной кислоты, в котором катализатор размещается за первым теплообменником котла-утилизатора после сжигания аммиака и перед абсорбционной колонной. Удаление N20 осуществляется путем пропускания реакционного газа над катализатором (патент RU 2 237 010 «Удаление веселящего газа»). Недостатком этого устройства является то, что для размещения катализатора необходима установка дополнительного аппарата. Задача данной полезной модели заключается в отказе от установки дополнительного ...

Подробнее
Номер записи: 6
27-01-2011 дата публикации

АГРЕГАТ ДЛЯ ПРОИЗВОДСТВА АЗОТНОЙ КИСЛОТЫ

Номер: RU0000101699U1
Автор:
Принадлежит: Закрытое акционерное общество "Астронит"

Агрегат для производства азотной кислоты из аммиака путем окисления аммиака кислородом воздуха и поглощения оксидов азота водой в агрегате с единым давлением на стадиях окисления аммиака и поглощения оксидов азота, содержащий аппараты окисления аммиака воздухом, поглощения оксидов азота, газотурбинную установку, включающую компрессор для сжатия воздуха и рекуперативную турбину для расширения хвостовых газов, нагретых газами из камеры сгорания топлива, а также смеситель воздуха и аммиака и его подогреватель, линию питательной воды для котла-утилизатора, имеющего паросборник, и продувочную колонну азотной кислоты, при этом компрессор установлен на одном валу с рекуперативной турбиной, на выходе из компрессора линия потока сжатого воздуха разделена на два ответвления, причем первое ответвление предназначено для получения азотной кислоты и связано сначала с охладителем сжатого воздуха и затем со смесителем аммиака, а второе ответвление предназначено для сжигания топлива и связано с камерой сгорания рекуперативной турбины, отличающийся тем, что агрегат дополнительно содержит инжектор, который установлен перед камерой сгорания, и сопло которого соединено со вторым ответвлением, а к патрубку всаса в инжектор подсоединен отвод от линии потока хвостового газа, перед воздухоохладителем выполнено третье ответвление, оснащенное регулирующим клапаном и соединенное с линией потока хвостового газа до отвода на инжектор, в качестве компрессора для сжатия воздуха в газотурбинной установке используют центробежный компрессор, причем центробежный компрессор и рекуперативная турбина установлены консольно с подшипниковым узлом между ними, для исключения утечки масла из которого в газовоздушный тракт расположены лабиринты, образующие предмасляную полость, наддуваемую воздухом из второго инжектора, сопло которого соединено с линией потока сжатого воздуха по четвертому ответвлению, а патрубок всаса в инжектор соединен с отводом от воздуховода к компрессору, у которого перед рабочим колесом ...

Подробнее
Номер записи: 7
27-05-2012 дата публикации

УЗЕЛ УТИЛИЗАЦИИ ТЕПЛА ОТХОДЯЩИХ ГАЗОВ В АГРЕГАТЕ УКЛ ПРОИЗВОДСТВА АЗОТНОЙ КИСЛОТЫ

Номер: RU0000116484U1
Автор: Рябчиков Александр Алексеевич
Принадлежит: Рябчиков Александр Алексеевич

1. Узел утилизации тепла отходящих газов в агрегате УКЛ производства азотной кислоты, который включает в себя как минимум один корпус самого узла, внутри которого расположен как минимум один экономайзер, теплообменные элементы которого соединяются с корпусом узла, отличающийся тем, что соединение теплообменных элементов с корпусом узла выполняется разъемным соединением. 2. Узел утилизации тепла отходящих газов в агрегате УКЛ производства азотной кислоты по п.1, отличающийся тем, что разъемное соединение выполняется фланцевым или сварным. 3. Узел утилизации тепла отходящих газов в агрегате УКЛ производства азотной кислоты по п.1, отличающийся тем, что теплообменные элементы экономайзера изготавливают с использованием оребренных труб. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 116 484 U1 (51) МПК C01B 21/40 (2006.01) B01J 8/02 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2011143550/05, 27.10.2011 (24) Дата начала отсчета срока действия патента: 27.10.2011 (72) Автор(ы): Рябчиков Александр Алексеевич (UA) (73) Патентообладатель(и): Рябчиков Александр Алексеевич (UA) R U Приоритет(ы): (22) Дата подачи заявки: 27.10.2011 (45) Опубликовано: 27.05.2012 Бюл. № 15 1 1 6 4 8 4 R U Формула полезной модели 1. Узел утилизации тепла отходящих газов в агрегате УКЛ производства азотной кислоты, который включает в себя как минимум один корпус самого узла, внутри которого расположен как минимум один экономайзер, теплообменные элементы которого соединяются с корпусом узла, отличающийся тем, что соединение теплообменных элементов с корпусом узла выполняется разъемным соединением. 2. Узел утилизации тепла отходящих газов в агрегате УКЛ производства азотной кислоты по п.1, отличающийся тем, что разъемное соединение выполняется фланцевым или сварным. 3. Узел утилизации тепла отходящих газов в агрегате УКЛ производства азотной кислоты по п.1, отличающийся тем, что теплообменные элементы экономайзера изготавливают с ...

Подробнее
Номер записи: 8
20-06-2012 дата публикации

УСТАНОВКА ДЛЯ ПОЛУЧЕНИЯ ПОРОШКООБРАЗНОГО НИТРИДА АЛЮМИНИЯ ВЫСОКОЙ ЧИСТОТЫ

Номер: RU0000117153U1
Автор: Афонин Юрий Дмитриевич, Баранов Михаил Владимирович, Бекетов Аскольд Рафаилович, Бекетов Дмитрий Аскольдович, Елагин Андрей Александрович, Шишкин Роман Александрович
Принадлежит: Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина"

1. Установка для получения порошкообразного нитрида алюминия высокой чистоты газофазным способом, состоящая из цилиндрической реакционной камеры, выполненной из жаропрочной стали и покрытой футеровочным материалом, расположенной на стальной пространственной раме и герметично соединенной с устройствами подачи азотсодержащих газов, подачи исходной шихты и выгрузки готового продукта, снабжена устройством нагрева, системами водного охлаждения, фильтрации и герметизации, отличающаяся тем, что цилиндрическая реакционная камера выполнена с возможностью вращения вокруг горизонтальной оси, футерована нитридом алюминия, расположена горизонтально на стальной пространственной раме, оснащена устройством для изменения угла наклона горизонтальной цилиндрической реакционной камеры, устройством нагрева в виде графитового нагревателя, создающего необходимый градиент температур вдоль горизонтальной цилиндрической реакционной камеры, установка снабжена системой очистки получаемого продукта от микропримесей. 2. Установка по п.1, характеризующаяся тем, что футеровочный материал, расположенный внутри цилиндрической реакционной камеры, выполнен в виде колец. 3. Установка по п.1, характеризующаяся тем, что в качестве системы очистки полученного материала от микропримесей использована печь отгонки солей, герметично соединенная с перчаточным боксом. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (51) МПК C30B 29/38 C01B 21/072 B82B 3/00 B82Y 40/00 (13) 117 153 U1 (2006.01) (2006.01) (2006.01) (2011.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2011149418/05, 05.12.2011 (24) Дата начала отсчета срока действия патента: 05.12.2011 (45) Опубликовано: 20.06.2012 Бюл. № 17 (73) Патентообладатель(и): Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" (RU) 1 1 7 1 5 3 R U Формула полезной модели 1. Установка для ...

Подробнее
Номер записи: 9
27-12-2012 дата публикации

МОБИЛЬНАЯ УСТАНОВКА ДЛЯ ПОЛУЧЕНИЯ АЗОТА

Номер: RU0000123405U1
Автор: Антуфьев Игорь Александрович, Шабалин Эдуард Николаевич
Принадлежит: Антуфьев Игорь Александрович, Шабалин Эдуард Николаевич

Мобильная установка для получения азота, содержащая цистерну на стандартной тележке и колесных парах и азотную мембранную установку, отличающаяся тем, что в качестве накопительной емкости для газа, поступающего от компрессора и азотной мембранной установки, используют цистерну, а в качестве компрессора используют двигатель внутреннего сгорания, в котором толкатель распределительного вала удален, клапан зажат пружиной, на место форсунки установлен обратный клапан, соединенный с ресивером гибким шлангом, а вращательное движение на вал двигателя, используемого в качестве компрессора, передается с осей колесных пар ременной или карданной передачей, при этом на тележке установлены приборные ящики для контроля давления в ресивере и давления, создаваемого двигателем-компрессором. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 123 405 U1 (51) МПК C01B 21/00 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2012117493/05, 28.04.2012 (24) Дата начала отсчета срока действия патента: 28.04.2012 (72) Автор(ы): Антуфьев Игорь Александрович (RU), Шабалин Эдуард Николаевич (RU) (45) Опубликовано: 27.12.2012 Бюл. № 36 R U (73) Патентообладатель(и): Антуфьев Игорь Александрович (RU), Шабалин Эдуард Николаевич (RU) Приоритет(ы): (22) Дата подачи заявки: 28.04.2012 Адрес для переписки: 127543, Москва-543, а/я 776, И.А. Антуфьеву U 1 1 2 3 4 0 5 R U Стр.: 1 U 1 Формула полезной модели Мобильная установка для получения азота, содержащая цистерну на стандартной тележке и колесных парах и азотную мембранную установку, отличающаяся тем, что в качестве накопительной емкости для газа, поступающего от компрессора и азотной мембранной установки, используют цистерну, а в качестве компрессора используют двигатель внутреннего сгорания, в котором толкатель распределительного вала удален, клапан зажат пружиной, на место форсунки установлен обратный клапан, соединенный с ресивером гибким шлангом, а вращательное движение на вал двигателя, ...

Подробнее
Номер записи: 10
10-09-2013 дата публикации

АГРЕГАТ ДЛЯ ПРОИЗВОДСТВА АЗОТНОЙ КИСЛОТЫ

Номер: RU0000132065U1
Автор: Кондратюк Вячеслав Владимирович, Никишечкин Вячеслав Леонидович
Принадлежит: Открытое акционерное общество "Дальневосточный завод энергетического машиностроения"

1. Агрегат для производства азотной кислоты из аммиака путем окисления аммиака кислородом воздуха и поглощением оксидов азота водой в агрегате с единым давлением на стадиях окисления аммиака и поглощения оксидов азота, содержащий аппараты окисления аммиака воздухом, поглощения оксидов азота, газотурбинную установку, включающую компрессор для сжатия воздуха и рекуперационную турбину для расширения хвостовых газов, нагретых газами из камеры сгорания топлива, а также смеситель аммиака и его подогреватель, линию питательной воды для котла-утилизатора, имеющего паросборник, и продувочную колонну азотной кислоты, при этом в газотурбинной установке в качестве компрессора для сжатия воздуха используют осевой компрессор, установленный непосредственно на одном валу с рекуперационной турбиной и у которого на выходе из компрессора линия потока сжатого воздуха разделена на две части, одна из которых, предназначенная для получения азотной кислоты, связана сначала с охладителем сжатого воздуха, например в виде «кипящего» экономайзера, соединенного с линией питательной воды, и затем со смесителем аммиака, а вторая, предназначенная для сжигания топлива, непосредственно с камерой сгорания рекуперативной турбины, отличающийся тем, что на выходе из компрессора линия потока сжатого воздуха имеет дополнительную часть, связанную с зоной концевых уплотнений для запирания и исключения протечек рабочего газа из проточной части турбины и предназначенную для охлаждения дисков рекуперационной турбины. 2. Агрегат для производства азотной кислоты по п.1, отличающийся тем, что в качестве валоповоротного устройства использован пусковой двигатель с частотным регулированием. И 1 132065 ко РОССИЙСКАЯ ФЕДЕРАЦИЯ ВУ” 132 065” 44 ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ИЗВЕЩЕНИЯ К ПАТЕНТУ НА ПОЛЕЗНУЮ МОДЕЛЬ ММ9К Досрочное прекращение действия патента из-за неуплаты в установленный срок пошлины за поддержание патента в силе Дата прекращения действия патента: 04.12.2020 Дата внесения ...

Подробнее
Номер записи: 11
20-01-2016 дата публикации

ГЕНЕРАТОР АЗОТА

Номер: RU0000159018U1
Автор: Гулянский Михаил Александрович, Потехин Сергей Владимирович, Стецко Алексей Николаевич
Принадлежит: Закрытое акционерное общество "Грасис"

Генератор азота для создания инертной технологической газовой среды, содержащий входной нагнетательный блок, рефрижераторный охладитель, соединенный с ним блок фильтрации, газоразделительный блок с полупроницаемой мембраной и подсоединенный к надмембранной полости газоразделительного блока выходной патрубок для подачи азота потребителю, отличающийся тем, что он снабжен дополнительным 2-х поточным рекуперативным противоточным теплообменником, установленным между блоком фильтрации и газоразделительным блоком, причем входной нагнетательный блок соединен с рефрижераторным охладителем через дополнительный 2-х поточный рекуперативный противоточный теплообменник. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (51) МПК B01D 53/00 B01D 53/22 B01J 7/00 C01B 21/02 B01D 61/00 B01D 63/00 (13) 159 018 U1 (2006.01) (2006.01) (2006.01) (2006.01) (2006.01) (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2015120195/05, 28.05.2015 (24) Дата начала отсчета срока действия патента: 28.05.2015 (73) Патентообладатель(и): Закрытое акционерное общество "Грасис" (RU) (45) Опубликовано: 20.01.2016 Бюл. № 2 R U 1 5 9 0 1 8 Формула полезной модели Генератор азота для создания инертной технологической газовой среды, содержащий входной нагнетательный блок, рефрижераторный охладитель, соединенный с ним блок фильтрации, газоразделительный блок с полупроницаемой мембраной и подсоединенный к надмембранной полости газоразделительного блока выходной патрубок для подачи азота потребителю, отличающийся тем, что он снабжен дополнительным 2-х поточным рекуперативным противоточным теплообменником, установленным между блоком фильтрации и газоразделительным блоком, причем входной нагнетательный блок соединен с рефрижераторным охладителем через дополнительный 2-х поточный рекуперативный противоточный теплообменник. Стр.: 1 U 1 U 1 (54) ГЕНЕРАТОР АЗОТА 1 5 9 0 1 8 Адрес для переписки: 115114, Москва, Шлюзовая наб., 6, стр. 4-5, ООО "Патент-Гарант", ...

Подробнее
Номер записи: 12
13-10-2017 дата публикации

Генератор азота

Номер: RU0000174454U1
Автор: Борисенко Василий Викторович
Принадлежит: Общество с ограниченной ответственностью "Челябинский завод мобильных энергоустановок и конструкций"

Полезная модель относится к установкам для производства газообразного азота из сжатого воздуха и может применяться в промышленности, в частности на объектах пищевой промышленности для создания модифицированной газовой среды при хранении и упаковке пищевой продукции, на объектах фармацевтической промышленности при упаковке медицинских препаратов и работе с мелкодисперсными веществами, на объектах химической, нефтехимической, нефтеперерабатывающей промышленности, на машиностроительных предприятиях при сварке, лазерной резке для создания инертной среды, на машиностроительных предприятиях при исследовательской и лабораторной деятельности, на приборостроительных предприятиях при производстве полупроводников и микросхем. Генератор азота содержит две адсорбционные колонны, шкаф управления, трубопровод с арматурой и глушителем, контрольно-измерительные приборы, после адсорбционных колонн расположен участок трубопровода с автоматически изменяемой пропускной способностью, состоящий из набора электропневматических клапанов с дросселирующими элементами. Техническим результатом полезной модели является выработка газообразного азота с чистотой задаваемой пользователем в диапазоне до 99,9999% и не зависящей от характеристик сжатого воздуха, поступающего на вход генератора. И 1 174454 ко РОССИЙСКАЯ ФЕДЕРАЦИЯ ‘7 ВУ’ 174 454`° 41 ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ИЗВЕЩЕНИЯ К ПАТЕНТУ НА ПОЛЕЗНУЮ МОДЕЛЬ ММ9К Досрочное прекращение действия патента из-за неуплаты в установленный срок пошлины за поддержание патента в силе Дата прекращения действия патента: 06.07.2019 Дата внесения записи в Государственный реестр: 25.03.2020 Дата публикации и номер бюллетеня: 25.03.2020 Бюл. №9 Стр.: 1 па УЧЗУТтДТ ЕП

Подробнее
Номер записи: 13
25-09-2018 дата публикации

Азотная компрессорная установка

Номер: RU0000183558U1
Автор: Бураков Александр Васильевич, Котов Олег Константинович, Кузнецов Леонид Григорьевич, Кузнецов Юрий Леонидович, Перминов Александр Сергеевич, Серебренников Сергей Николаевич
Принадлежит: Бураков Александр Васильевич, Котов Олег Константинович, Кузнецов Леонид Григорьевич, Кузнецов Юрий Леонидович, Перминов Александр Сергеевич, Серебренников Сергей Николаевич

Полезная модель относится к области машиностроения, а именно к компрессорным установкам для получения из атмосферного воздуха газовой смеси с высоким содержанием азота, используемой при выполнении технологических операций в различных отраслях промышленности. В частности, может применяться для получения азота высокого давления для наддува топливных баков и продувки топливных трубопроводов на авианесущих кораблях и судах. Азотная компрессорная установка, включающая в себя размещенные на единой раме винтовой и поршневой компрессоры с приводными электрическими двигателями, блок управления, блок подготовки воздуха с подогревателем, мембранный газоразделительный блок, на выходе которого установлен газоанализатор, при этом вход блока подготовки воздуха соединен с выходом винтового компрессора, мембранный газоразделительный блок подключен к выходу блока подготовки воздуха, а выход мембранного газоразделительного блока сообщен трубопроводом через запорно-регулирующий клапан с размещенными на раме двумя параллельно подключенными емкостями для газообразного азота, одна из которых через запорно-регулирующий клапан сообщена со входом в поршневой компрессор и далее с выходом азота высокого давления, причем емкости для газообразного азота дополнительно подключены к внешнему источнику азота низкого давления. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 183 558 U1 (51) МПК C01B 21/02 (2006.01) B01J 7/00 (2006.01) F04B 41/00 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (52) СПК C01B 21/02 (2018.08); B01J 7/00 (2018.08); F04B 41/00 (2018.08) (21)(22) Заявка: 2018127008, 24.07.2018 (24) Дата начала отсчета срока действия патента: Дата регистрации: 25.09.2018 (45) Опубликовано: 25.09.2018 Бюл. № 27 Адрес для переписки: 194044, Санкт-Петербург, Б. Сампсониевский пр., 64, АО "Компрессор", пат. пов. Подоксику М.Я. (73) Патентообладатель(и): Кузнецов Леонид Григорьевич (RU), Кузнецов Юрий Леонидович (RU), Бураков Александр Васильевич (RU), ...

Подробнее
Номер записи: 14
01-08-2019 дата публикации

ТРЕХФАЗНЫЙ РЕАКТОР СМЕШЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ГИДРОКСИЛАМИНСУЛЬФАТА

Номер: RU0000191339U1
Автор: Ардамаков Сергей Витальевич, Герасименко Александр Викторович, Лукьянов Игорь Валентинович
Принадлежит: Публичное акционерное общество "КуйбышевАзот"

Полезная модель относится к области производства гидроксиламинсульфата (ГАС) каталитическим гидрированием оксида азота (II) водородом в жидкой фазе в среде водного раствора серной кислоты в присутствии гетерогенного катализатора «платина на электрографите». ГАС используется в качестве одного из основных реагентов при синтезе капролактама. Трехфазный реактор смешения для получения гидроксиламинсульфата гидрированием водородом оксида азота (II) в среде серной кислоты при повышенной температуре и повышенном давлении в присутствии мелкодисперсного катализатора «платина на электрографите», состоящий из эллиптического днища, эллиптической крышки и цилиндрического корпуса, соединенных фланцами, имеющих устройства ввода-вывода жидких реагентов и продуктов реакции, снабженный мешалкой для перемешивания реакционной смеси и имеющий барботер для ввода газообразных реагентов и вывода газообразных продуктов реакции. Барботер состоит из двух зон, разделенных между собой непроницаемой перегородкой, имеющей горизонтальное расположение и позволяющей осуществлять раздельный ввод водорода и оксида азота (II) в реакционную зону, причем ввод водорода осуществляют из зоны, расположенной ниже перегородки. 2 ил. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 191 339 U1 (51) МПК B01J 8/10 (2006.01) B01J 19/18 (2006.01) C01B 21/14 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (52) СПК B01J 8/10 (2019.05); B01J 19/18 (2019.05); C01B 21/14 (2019.05) (21)(22) Заявка: 2019110884, 11.04.2019 (24) Дата начала отсчета срока действия патента: Дата регистрации: (73) Патентообладатель(и): Публичное акционерное общество "КуйбышевАзот" (RU) 01.08.2019 (56) Список документов, цитированных в отчете о поиске: RU 2330715 С1,10.08.2008. RU 2389542 С1, 20.05.2010. SU 1237629 A1, 15.06.1986. US 7608236 В2, 27.10.2009. (45) Опубликовано: 01.08.2019 Бюл. № 22 1 9 1 3 3 9 R U (54) ТРЕХФАЗНЫЙ РЕАКТОР СМЕШЕНИЯ ДЛЯ ПОЛУЧЕНИЯ ГИДРОКСИЛАМИНСУЛЬФАТА (57) Реферат: Полезная ...

Подробнее
Номер записи: 15
17-02-2020 дата публикации

РЕАКТОР ПОЛУЧЕНИЯ ГИДРОКСИЛАМИНСУЛЬФАТА

Номер: RU0000196107U1
Автор: Ардамаков Сергей Витальевич, Герасименко Александр Викторович
Принадлежит: Публичное акционерное общество "КуйбышевАзот"

Предложен реактор синтеза гидроксиламинсульфата гидрированием водородом оксида азота (II) в водном растворе серной кислоты в присутствии мелкодисперсного катализатора «платина на электрографите». Гидроксиламинсульфат является прекурсором для синтеза капролактама -одного из основных компонентов производства пластмасс полиамидной группы. Реактор имеет цилиндрический корпус, эллиптические крышку и днище, перемешивающее устройство и устройства ввода и вывода газообразных и жидких компонентов. Особенностью данной конструкции реактора является соосное расположение в центре реактора трех труб различного диаметра, с помощью которых осуществляют перемешивание и раздельную подачу в реакционный объем газообразных реагентов - водорода и оксида азота (II). Ввод водорода в реакционный объем проводят с помощью полой тарелки, жестко закрепленной в нижней части реактора и фиксирующей положение трех труб внутри реактора. Охлаждение реакционной массы осуществляют с помощью внешней рубашки и путем циркуляции водного раствора серной кислоты и продуктов реакции через дополнительное устройство для охлаждения, расположенное снаружи реактора. Высокая надежность конструкции реактора, интенсивное перемешивание и проведение процесса в кинетической области, раздельная подача в реакционный объем газообразных реагентов и др. обеспечивают взрывобезопасный режим процесса и высокий выход целевого продукта. 1 фиг. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 196 107 U1 (51) МПК C01B 21/14 (2006.01) B01J 19/18 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (52) СПК C01B 21/14 (2020.01); B01J 19/18 (2020.01) (21)(22) Заявка: 2019139772, 04.12.2019 (24) Дата начала отсчета срока действия патента: (73) Патентообладатель(и): Публичное акционерное общество "КуйбышевАзот" (RU) Дата регистрации: 17.02.2020 (56) Список документов, цитированных в отчете о поиске: RU 2389542 C1, 20.05.2010. RU 2330715 C1, 10.08.2008. RU 2296006 C2, 27.03.2007. RU 2225752 C1, 20. ...

Подробнее
Номер записи: 16
26-01-2012 дата публикации

Method of processing liquid chlorine containing nitrogen trichloride

Номер: US20120020866A1
Автор: Clive Brereton, Sergio Berretta
Принадлежит: Noram International Ltd

A method of processing a stream of liquid chlorine containing nitrogen trichloride from a chloralkali plant. The liquid stream is received into a vaporizer in which it is evaporated 1O1 chlorine gas and nitrogen trichloride gas. The gas stream is processed by destroying the nitrogen trichloride gas, for example in a superheater or a catalytic bed. The processed gas stream is recycled to the chlorine production train of the chloralkali plant. The process avoids the use of organic solvents to decompose the nitrogen trichloride and the creation of a waste stream requiring further handling.

Подробнее
Номер записи: 17
15-03-2012 дата публикации

Oxygen enrichment device for ventilator

Номер: US20120060841A1
Автор: Clayton Roy Platt, Richard William Crawford, Jr.
Принадлежит: Newport Medical Instruments Inc

An enrichment device for mixing ambient air with a gas such as oxygen has a rigid outer housing defining a reservoir. The housing has an outlet port for attachment to a cyclic low pressure source, an ambient air inlet, and a second inlet for connection to a supply of pressurized gas. The reservoir has a plurality of internal walls defining a passageway having a plurality of turns defining a tortuous path for gas flow between the ambient air inlet and the outlet port, and the second inlet communicates with the passageway at a location at or close to the outlet port.

Подробнее
Номер записи: 18
22-03-2012 дата публикации

Phosphor particle group and light emitting apparatus using the same

Номер: US20120068595A1
Автор: Kenji Terashima, Masatsugu Masuda, Tetsuya Hanamoto
Принадлежит: Sharp Corp

Provided is a phosphor particle group of divalent europium-activated oxynitride green light emitting phosphor particles each of which is a β-type SiAlON substantially represented by a general formula: EuaSibAlcOdNe, where 0.005≦a≦0.4, b+c=12, d+e=16, wherein 60% or more of the phosphor particle group is composed of the phosphor particles in which a value obtained by dividing a longer particle diameter by a shorter particle diameter is greater than 1.0 and not greater than 3.0. A high-efficiency and stable light emitting apparatus using a β-type SiAlON, which includes a light converter using the phosphor particle group, and a phosphor particle group therefor are also provided.

Подробнее
Номер записи: 19
03-05-2012 дата публикации

Device and Methods for Applying Therapeutic Protocols to Organs of the Cardiopulmonary System

Номер: US20120103337A1
Автор: Yuval Avni
Принадлежит: RESPINOVA Ltd

The invention is a device for the introduction of a fluid into a human's airway. The air so introduced has a carefully modulated envelope of pressure vs. time, this envelope generally consisting of sequences of pressurized air packets of controlled frequency and pressures. The device produces these packets by means of pressurized air occluded by a shutter action which “chops” and interrupts the fluid stream. The vibrations induced by the device within human organs have been shown to have beneficial effects on various bodily systems, such as increase in heart rate variability, increase in absorbed oxygen, decrease in absorbed CO2, and the like.

Подробнее
Номер записи: 20
17-05-2012 дата публикации

Method and device for preventing corrosion on a gas inlet nozzle during nitric acid condensation

Номер: US20120119395A1
Автор: Rainer Maurer
Принадлежит: THYSSENKRUPP UHDE GMBH

By a method and a device for preventing corrosion on and in the region of a gas inlet nozzle during nitric acid condensation, contact of the condensing gas with the nozzle and with the surroundings of the nozzle are supposed to be minimized. This is achieved in that the gas inlet nozzle has a sleeve on the inside in the transition region to the interior of the condenser, by which sleeve a gas inlet orifice in the form of an annular gap is formed, whereby the annular space is provided with at least one feed opening for secondary air, so that an enveloping flow of secondary air is produced around the entering NO gas.

Подробнее
Номер записи: 21
24-05-2012 дата публикации

Destruction of ammonium ions

Номер: US20120128569A1
Автор: Carlos Lopez Cruz, Hendrik Oevering, Rudolf Philippus Maria Guil, Theodorus Friederich Maria Riesthuis
Принадлежит: DSM IP ASSETS BV

The invention relates to a process for converting ammonium formed in a hydroxylamine phosphate oxime process into molecular nitrogen in an ammonium destruction zone, comprising—preparing a vapour stream comprising nitrogen oxide from ammonia, in an ammonia combustion zone;—bringing into contact by feeding to the ammonium destruction zone, individually and/or as pre-mixed combinations, at least part of said vapour stream, and a first liquid stream, comprising ammonium formed in the hydroxylamine phosphate oxime process, and a second liquid stream, comprising at least one acid selected from nitric acid and nitrous acid in a total nitric+nitrous acid concentration of at least 30 wt. %, thereby forming in the ammonium destruction zone a fluid mixture; and—reacting ammonium ions in the fluid mixture with nitrogen oxide under formation of molecular nitrogen, in the ammonium destruction zone. The invention further relates to an installation for converting ammonium formed in a hydroxylamine phosphate oxime process.

Подробнее
Номер записи: 22
12-07-2012 дата публикации

(oxy) nitride phosphor, white light-emitting device including the (oxy) nitride phosphor, method of preparing phosphor, and nitride phosphor prepared by the method

Номер: US20120176026A1
Автор: Seoung-jae Im, Shunichi Kubota, Tae-Gon Kim, Young-Sic Kim
Принадлежит: Samsung Electro Mechanics Co Ltd

Provided is an (oxy)nitride phosphor, which is a compound represented by Formula 1 below: {M( 1-x) Eu x } a Si b O c N d   <Formula 1> wherein, M is an alkaline earth metal; and 0<x<1, 1.8<a<2.2, 4.5<b<5.5, 0≦c<8, 0<d≦8, and 0<c+d≦8. The (oxy)nitride phosphor produces red light suitable for use in UV-LED and blue-LED type white light-emitting devices and achieves good efficiency.

Подробнее
Номер записи: 23
23-08-2012 дата публикации

Synergistic methods for odor control

Номер: US20120213662A1
Автор: David L. Morano, James P. Harshman, Timothy F. Matheis
Принадлежит: Siemens Industry Inc

An odor control composition may be dosed to a wastewater treatment system to control hydrogen sulfide levels. The composition may include a sulfide-reducing agent and an oxidizer. Synergy between the compounds of the odor control composition may facilitate efficient reduction of hydrogen sulfide levels. The sulfide-reducing agent and the oxidizer may be present in a single odor control composition or may be dosed to the system separately.

Подробнее
Номер записи: 24
04-10-2012 дата публикации

Moisture-proof film, method for manufacturing the same, and organic electronic device including the same

Номер: US20120248975A1
Автор: Manabu Niboshi
Принадлежит: Sharp Corp

A moisture-proof film ( 10 ) includes a moisture-proof part ( 12 ) formed on a surface of a film body ( 11 ). The moisture-proof part ( 12 ) includes a first layer ( 11 a ) made of a silicon oxycarbonitride compound containing carbon atoms in a composition thereof, and a second layer ( 11 b ) made of a silicon oxynitride compound which, in a composition thereof, contains carbon atoms less than those of the first layer ( 11 a ) or does not contain carbon atoms, and having a density higher than that of the first layer ( 11 a ). The first and second layers ( 11 a, 11 b ) are stacked adjoining each other. The first layer ( 11 a ) has a density increasing toward the second layer ( 11 b ).

Подробнее
Номер записи: 25
13-12-2012 дата публикации

Process for producing fuel cell electrode catalyst, process for producing transition metal oxycarbonitride, fuel cell electrode catalyst and uses thereof

Номер: US20120315568A1
Автор: Chunfu Yu, Kazunori Ichioka, Kenichiro Ota, Kunchan Lee, Masaki Horikita, Ryoko Konta, Ryuji Monden, Takashi Sato, Takuya Imai, Yasuaki Wakizaka
Принадлежит: Showa Denko KK

Provided is a process for producing a fuel cell electrode catalyst having high catalytic activity which uses a transition metal, e.g., titanium, which process comprises thermal treatment at relatively low temperature, i.e., not including thermal treatment at high temperature (calcining) step. The process for producing a fuel cell electrode catalyst comprises a step ( 1 ) of mixing at least a transition metal-containing compound, a nitrogen-containing organic compound and a solvent to provide a catalyst precursor solution; a step ( 2 ) of removing the solvent from the catalyst precursor solution; and a step ( 3 ) of thermally treating a solid residue obtained in the step ( 2 ) at a temperature of 500 to 1100° C. to provide an electrode catalyst; wherein the transition metal-containing compound is partly or wholly a compound comprising at least one transition metal element (M1) selected from the group 4 and 5 elements of the periodic table as a transition metal element.

Подробнее
Номер записи: 26
17-01-2013 дата публикации

Filler for filling a gap, method of preparing the same and method of manufacturing semiconductor capacitor using the same

Номер: US20130017662A1
Автор: Bong-Hwan Kim, Eun-Su PARK, Hui-Chan Yun, Jin-Hee Bae, Jin-Wook Lee, Sang-Hak Lim, Sang-kyun Kim, Taek-Soo Kwak
Принадлежит: Cheil Industries Inc

A filler for filling a gap includes a compound represented by the following Chemical Formula 1. [Chemical Formula 1] Si a N b O c H d . In Chemical Formula 1, a, b, c, and d represent relative amounts of Si, N, O, and H, respectively, in the compound, 1.96<a<2.68, 1.78<b<3.21, 0≦c<0.19, and 4<d<10.

Подробнее
Номер записи: 27
21-02-2013 дата публикации

Zn5(BTA)6(TDA)2 - A ROBUST HIGHLY INTERPENETRATED METAL-ORGANIC FRAMEWORK CONSTRUCTED FROM PENTANUCLEAR CLUSTERS FOR SELECTIVE SORPTION OF GAS MOLECULES

Номер: US20130043407A1
Автор: Banglin Chen, Shengchang Xiang
Принадлежит: University of Texas System

Disclosed herein are highly interpenetrated robust metal-organic frameworks having the repeat unit Zn 5 (BTA) 6 (TDA) 2 , useful for applications such as selective gas storage, selective gas sorption and/or separation, and gas detection.

Подробнее
Номер записи: 28
28-02-2013 дата публикации

Gas separations with redox-active metal-organic frameworks

Номер: US20130053585A1
Автор: Eric D. Bloch, Jeffrey R. Long, Leslie Murray
Принадлежит: UNIVERSITY OF CALIFORNIA

Fe 2 (dobdc) has a metal-organic framework with a high density of coordinatively-unsaturated Fe II centers lining the pore surface. It can be effectively used to separate O 2 from N 2 and in a number of additional separation applications based on selective, reversible electron transfer reactions. In addition to being an effective O 2 separation material, it can be used for many other processes, including paraffin/olefin separation, nitric oxide/nitrous oxide separation, acetylene storage, and as an oxidation catalyst.

Подробнее
Номер записи: 29
14-03-2013 дата публикации

METAL IMIDE COMPOUNDS AS ANODE MATERIALS FOR LITHIUM BATTERIES AND GALVANIC ELEMENTS WITH A HIGH STORAGE CAPACITY

Номер: US20130062575A1
Автор: Wietelmann Ulrich
Принадлежит: Chemetall GmbH

Metal imide compounds as anode materials for lithium batteries and galvanic elements with a high storage capacity. Metal imide compounds as highly capacitive anode materials for lithium batteries. The invention relates to a galvanic element, an anode material for use in a galvanic element and method for producing an active electrode material. The galvanic element contains the metal imide compounds of the general formula (I): MM(NH)·y MNH(I), where M=alkali metal (Li, Na, K, Rb, Cs or any desired mixture thereof), M=alkaline earth metal element (Mg, Ca, Sr, Ba or any desired mixture thereof), and x and y independently of one another represent a number between 0 and 1 in the discharged state, or the metal imide compounds of the general formula (II): LiMM(NH)·y LiH (II), where M=alkali metal (Li, Na, K, Rb, Cs or any desired mixture thereof), M=alkaline earth metal element (Mg, Ca, Sr, Ba or any desired mixture thereof), and x and y independently of one another represent a number between 0 and 1 in the charged state. 120.-. (canceled)21. A galvanic element comprising a metal imide compound of formula (I){'br': None, 'sup': 1', '2', '1, 'sub': 4-2x', 'x', '2', '2, 'MM(NH)·yMNH\u2003\u2003(I), wherein'}M1 is an alkali metal selected from the group consisting of Li, Na, K, Rb, Cs;M2 is an alkaline earth element elected from the group consisting if Mg, Ca, Sr and Ba;x and y each independently represent a number between 0 and 1 in the discharged state, {'br': None, 'sub': 4', '4-2x', 'x', '2, 'sup': 1', '2, 'LiMM(NH)·yLiH \u2003\u2003(II), wherein'}, 'or a metal imide of formula (II)'}{'sup': '1', 'Mis an alkali metal selected from the group consisting of Li, Na, K, Rh, Cs;'}{'sup': '2', 'Mis an alkaline earth element elected from the group consisting if Mg, Ca, Sr and Ba;'}x and y independently represent a number between 0 and 1in the charged state.2220. A galvanic element according to claim , wherein in the discharged state the galvanic element a metal imide of formula (I ...

Подробнее
Номер записи: 30
21-03-2013 дата публикации

METHODS OF DISTRIBUTING A PHARMACEUTICAL PRODUCT COMPRISING NITRIC OXIDE GAS FOR INHALATION

Номер: US20130068223A1
Автор: Baldassarre James S., Rosskamp Ralf
Принадлежит: INO THERAPEUTICS LLC

Disclosed are methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation. 1. A method of distributing a pharmaceutical product , the method comprising:providing a source of nitric oxide gas to a medical provider;informing the medical provider that a recommended dose of inhaled nitric oxide gas for treatment of neonates with hypoxic respiratory failure is 20 ppm nitric oxide;providing a first warning to the medical provider that inhaled nitric oxide is contraindicated in the treatment of neonates dependent on right-to-left shunting of blood; andproviding a second warning to the medical provider, distinct from the first warning, that in patients with pre-existing left ventricular dysfunction, inhaled nitric oxide may increase pulmonary capillary wedge pressure (PCWP) leading to pulmonary edema, the second warning being sufficient to cause a medical provider considering inhaled nitric oxide treatment for a plurality of neonatal patients who (a) are suffering from a condition for which inhaled nitric oxide is indicated, and (b) have pre-existing left ventricular dysfunction, to elect to avoid treating one or more of the plurality of patients with inhaled nitric oxide in order to avoid putting the one or more patients at risk of pulmonary edema.2. The method of claim 1 , further comprising generating the source of nitric oxide gas prior to providing the source to the medical provider.3. The method of claim 2 , wherein the source of nitric oxide gas is a gaseous blend of nitric oxide and nitrogen.4. The method of claim 1 , further comprising generating the source of nitric oxide gas by a method comprising compressing nitric oxide and nitrogen gases under high pressure claim 1 , prior to providing the source to the medical provider.5. The method of claim 1 , wherein the source of nitric oxide gas is a gaseous blend of nitric oxide and nitrogen provided as a compressed gas in a cylinder under high pressure.6. The method of claim 1 , wherein ...

Подробнее
Номер записи: 31
21-03-2013 дата публикации

ALKALI METAL SALT OF FLUOROSULFONYL IMIDE, AND PRODUCTION METHOD THEREFOR

Номер: US20130068991A1
Автор: OKUMURA Yasunori, SATO Shimpei, Sato Yuichi
Принадлежит:

The present invention provides an alkali metal salt of fluorosulfonyl imide having favorable heat resistance and a reduced content of specific impurities and a water content, and provides a method for producing an alkali metal salt of fluorosulfonyl imide, which is capable of easily removing a solvent from a reaction solution. An alkali metal salt of fluorosulfonyl imide of the present invention is represented by the following general formula (I) and has a mass loss rate of 2% or less when the alkali metal salt of fluorosulfonyl imide is kept at 100° C. for 8 hours under an air current. A method for producing an alkali metal salt of fluorosulfonyl imide of the present invention comprises a step of concentrating a solution of the alkali metal salt of fluorosulfonyl imide by bubbling a gas into a reaction solution containing the alkali metal salt of fluorosulfonyl imide, and/or concentrating a solution of the alkali metal salt of fluorosulfonyl imide by thin layer distillation. 117-. (canceled)20. The alkali metal salt of fluorosulfonyl imide according to or , wherein a content of fluoride ions (F) is 1 ,000 ppm or less.21. The alkali metal salt of fluorosulfonyl imide according to claim 20 , wherein a water content is 500 ppm or less.22. The alkali metal salt of fluorosulfonyl imide according to claim 21 , further comprising 4 claim 21 ,000 ppm or less of a residual solvent.23. The alkali metal salt of fluorosulfonyl imide according to or claim 21 , wherein the alkali metal salt of fluorosulfonyl imide is an alkali metal salt of bis(fluorosulfonyl)imide.24. The alkali metal salt of fluorosulfonyl imide according to or claim 21 , wherein the alkali metal salt of fluorosulfonyl imide is selected from a sodium salt claim 21 , a potassium salt or a lithium salt.25. The alkali metal salt of fluorosulfonyl imide according to claim 21 , wherein the alkali metal salt of fluorosulfonyl imide is an alkali metal salt of bis(fluorosulfonyl)imide.26. The alkali metal salt of ...

Подробнее
Номер записи: 32
21-03-2013 дата публикации

Ordered Oxynitride Perovskites

Номер: US20130071312A1
Автор: CARACAS Razvan, COHEN Ronald
Принадлежит:

This invention relates to partially ordered and ordered oxynitride perovskites of the general formula ABON that are polar insulators. A comprises one or more cations or set of cations that sit in sites derived from the A-site in the perovskite structure. B comprises one or more cations or set of cations that sit in sites derived from the B-site in the perovskite structure. C comprises oxygen, O, with optionally some nitrogen, N, and D comprises N, with optionally some O. The total valence of the cations A+B is equal to the total valence of the anions 2 C+D. Also disclosed are methods of producing such oxynitride perovskites and uses of such oxynitride perovskites. 2. (canceled)3. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is dielectric.4. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is a polar insulator.5. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is piezoelectric.6. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is ferroelectric.7. (canceled)8. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is YGeON.9. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is GaTiON.10. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is InTiON.11. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is BiZrON.12. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is YCON.13. The oxynitride perovskite of claim 1 , wherein the oxynitride perovskite is selected from the group consisting of BiTiON claim 1 , YTiON claim 1 , YZrON claim 1 , and YSnON.14. A composition comprising an oxynitride perovskite of .15. A crystal comprising an oxynitride perovskite of .16. A composition comprising one or more crystals of .17. A non-linear optic material comprising an oxynitride perovskite of .18. A neutron generator comprising an oxynitride perovskite of .20. The oxynitride ...

Подробнее
Номер записи: 33
21-03-2013 дата публикации

NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS

Номер: US20130071494A1
Автор: Bryan Nathan S., Zand Janet
Принадлежит:

Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of said composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided. 1. A composition , comprising:from about 40 weight parts to about 1000 weight parts of a botanical nitrate source;from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; andfrom about 4 weight parts to about 100 weight parts of a nitrite salt.2Schisandra,. The composition of claim 1 , wherein the botanical nitrate source is selected from the group consisting of beet root claim 1 , artichoke claim 1 , holy basil claim 1 , gymnema sylvestre claim 1 , L9H claim 1 , ashwagandha root claim 1 , salvia claim 1 , St. John wort claim 1 , broccoli claim 1 , stevia claim 1 , spinach claim 1 , gingko claim 1 , kelp claim 1 , tribulus claim 1 , eleuthero claim 1 , epimedium claim 1 , eucommia claim 1 , hawthorn berry claim 1 , rhodiola claim 1 , green tea claim 1 , codonopsys claim 1 , panax ginseng claim 1 , astragalus claim 1 , pine bark claim 1 , dodder seed claim 1 , cordyceps claim 1 , and mixtures thereof.3Schisandra,. The composition of claim 1 , wherein the botanical source of nitrite reduction activity is selected from the group consisting of hawthorn berry claim 1 , green tea claim 1 , beet root claim 1 , pine bark claim 1 , holy basil claim 1 , gymnema sylvestre claim 1 , L9H claim 1 , ashwagandha root claim 1 , salvia claim 1 , St. John wort claim 1 , broccoli claim 1 , stevia claim 1 , spinach claim 1 , gingko claim 1 , kelp claim 1 , tribulus claim 1 , eleuthero claim 1 , epimedium claim 1 , eucommia claim 1 , rhodiola claim 1 , green tea claim 1 , codonopsys claim 1 , panax ginseng claim 1 , astragalus claim 1 , ...

Подробнее
Номер записи: 34
21-03-2013 дата публикации

CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT

Номер: US20130071496A1
Автор: Andersen Jens E.T., Christgau Stephen, Hansen Christian, Nilsson Henrik
Принадлежит: Osteologix A/S

A controlled release pharmaceutical composition comprising a strontium salt. The invention also relates to the use of a strontium salt for treating a male suffering from diseases and conditions affecting metabolism and/or structural integrity of cartilage and/or bone. The invention also relates to the use of a strontium-containing compound for preventing a cartilage and/or bone condition in a subject, and for the treatment and/or prophylaxis of secondary osteoporosis. 160.-. (canceled)61. A method for treatment and/or prophylaxis of a bone disease and/or condition resulting in a dysregulation of bone metabolism in a subject in need thereof , the method comprising administering to the subject a pharmaceutical composition for oral administration once daily comprising one or more strontium salts , wherein the amount of the one or more strontium salts is adjusted so that the composition is for oral administration once daily; and wherein the one or more strontium salts comprise strontium malonate , strontium succinate , strontium glutamate , strontium alpha-ketoglutarate , strontium maleate , strontium pyruvate , strontium aspartate , strontium citrate , strontium fumarate , strontium tartrate or strontium glutarate.62. The method of claim 61 , wherein the pharmaceutical composition further comprises one or more pharmaceutically acceptable excipients.63. The method of claim 61 , wherein the one or more strontium salts comprise strontium succinate.64. The method of claim 61 , wherein the bone disease and/or condition comprises osteoporosis claim 61 , osteopetrosis claim 61 , osteopenia claim 61 , Paget's disease claim 61 , hypercalcemia of malignancy claim 61 , osteodystrophy claim 61 , malignant hypercalcemia claim 61 , osteolytic lesions produced by bone metastasis claim 61 , bone pain due to bone metastasis claim 61 , bone loss due to sex steroid hormone deficiency claim 61 , bone abnormalities due to steroid hormone treatment claim 61 , bone abnormalities caused by ...

Подробнее
Номер записи: 35
28-03-2013 дата публикации

HOUSING FOR SOLID, FLUIDAL SUBSTANCE FOR REMOVING AN UNDESIRED RESPIRATORY GAS COMPONENT OF A RESPIRATORY GAS FLOW AND AN ARRANGEMENT FOR VENTILATING LUNGS OF A SUBJECT

Номер: US20130074837A1
Автор: Heinonen Erkki
Принадлежит:

A housing for a solid, fluidal substance for removing an undesired respiratory gas component of a respiratory gas flow, the housing comprising a space for receiving the solid, fluidal substance, a wall surrounding part of the space, a first separator surrounding part of the space, the first separator being configured to allow the respiratory gas to flow and to prevent the solid, fluidal substance from escaping from the space through the first separator, a second separator surrounding part of the space, the second separator being configured to allow the respiratory gas to flow and to prevent the solid, fluidal substance from escaping from the space through the second separator; and a limiter disposed between the first separator and the second separator, the limiter being configured to limit movement of the solid, fluidal substance inside the space. 2. The housing according to claim 1 , wherein the limiter is disposed closer to one of the first separator and the second separator than to midway between the first separator and the second separator.3. The housing according to claim 1 , wherein the limiter and one of the first separator and the second separator constitute an integral structure.4. The housing according to claim 1 , wherein the limiter extends from one of the first separator and the second separator towards the space.5. The housing according to claim 4 , wherein the limiter is configured to form compartments to limit the movement of the solid claim 4 , fluidal substance in various directions following one of the first separator and the second separator through the space.6. The housing according to claim 1 , wherein the limiter is configured to form a continuous structure following one of the first separator and the second separator through the space.7. The housing according to claim 1 , wherein the limiter comprises a first set of adjacent extensions.8. The housing according to claim 7 , wherein the adjacent extensions are substantially parallel.9. The ...

Подробнее
Номер записи: 36
28-03-2013 дата публикации

Nitrous Oxide Anesthetic Administration System

Номер: US20130074840A1
Автор: Ahearn David J., Carey Edward
Принадлежит:

The present invention is a method and system for administering nitrous oxide. The system includes a fluid control system for controlling the flow of nitrous oxide and oxygen to the patient. A nitrous oxide and oxygen supply, vacuum source, a breather bag, and a nasal delivery interface system are fluidly connected to the fluid control system and a patient. The fluid control system also includes a safety scavenge system including a mass airflow sensor, master controller, nitrous oxide valve, and alarm. The mass airflow sensor reads the scavenging vacuum pressure which it communicates to the master controller. Depending upon the scavenging vacuum pressure, the master controller can activate an alarm or shut off the flow of nitrous oxide. In operation, the present invention provides a system for administering anesthesia/analgesia gas which prevents excessively high volumes of exhaled nitrous oxide in the operatory environment through monitoring of the scavenge vacuum pressure. 1. A system for administering nitrous oxide to a patient , comprising:a fluid control system for controlling the flow of nitrous oxide and oxygen;a nasal delivery interface system fluidly connected to the fluid control system;a nitrous oxide and oxygen supply fluidly connected to the control system;a vacuum source fluidly connected to the scavenging tube for scavenging excess gases; a mass airflow sensor for reading scavenging vacuum pressure fluidly connected to the scavenging tube before the vacuum source;', 'a master controller in electrical communication with the mass airflow sensor for receiving the scavenging vacuum pressure reading from the mass airflow sensor which is compared to one or more predetermined ranges; and', 'a nitrous oxide valve fluidly connected to the nitrous oxide supply and in electrical communication with the master controller which shuts off the nitrous oxide shut-off valve when the scavenging vacuum pressure is less than a third predetermined range., 'the fluid control ...

Подробнее
Номер записи: 37
28-03-2013 дата публикации

SILICON NITRIDE FILM OF SEMICONDUCTOR ELEMENT, AND METHOD AND APPARATUS FOR PRODUCING SILICON NITRIDE FILM

Номер: US20130075875A1
Автор: Nishikawa Seiji
Принадлежит: MITSUBISHI HEAVY INDUSTRIES, LTD.

Disclosed are: a silicon nitride film of a semiconductor element, which is formed by applying a bias power and appropriately controls hydrogen leaving from the silicon nitride film; and a method and apparatus for producing a silicon nitride film. Specifically disclosed is a silicon nitride film which is formed on a substrate () by plasma processing and used in a semiconductor element. If the silicon nitride film is in contact with a film () to which supply of hydrogen is required to be shut off, the silicon nitride film is configured of a biased SiN () that is formed by applying a bias to the substrate () and an unbiased SiN () that is formed without applying a bias to the substrate () and the unbiased SiN () is arranged on the side on which the silicon nitride film is in contact with the film (). 1. A silicon nitride film of a semiconductor element formed on a substrate by plasma processing and to be used in the semiconductor element , wherein the silicon nitride film comprises a first silicon nitride film formed by applying bias to the substrate, and a second silicon nitride film formed without applying any bias to the substrate, and', 'the second silicon nitride film is disposed on a side which is in contact with the film., 'in a case where the silicon nitride film is in contact with a film desired to be blocked from being supplied with hydrogen,'}2. A silicon nitride film of a semiconductor element formed on a substrate by plasma processing and to be used in the semiconductor element , wherein the silicon nitride film comprises a first silicon nitride film formed by applying bias to the substrate, and a second silicon nitride film formed without applying any bias to the substrate, and', 'the first silicon nitride film is disposed on a side which is in contact with the film., 'in a case where the silicon nitride film is in contact with a film desired to be supplied with hydrogen,'}3. A method for producing a silicon nitride film to be used in a semiconductor ...

Подробнее
Номер записи: 38
28-03-2013 дата публикации

METHODS FOR TREATING PATIENTS WHO ARE CANDIDATES FOR INHALED NITRIC OXIDE TREATMENT

Номер: US20130078321A1
Автор: Baldassarre James S., Rosskamp Ralf
Принадлежит: INO THERAPEUTICS LLC

Disclosed are methods of reducing the risk that a medical treatment comprising inhalation of nitric oxide gas will induce an increase in pulmonary capillary wedge pressure in the patient, leading to pulmonary edema. 1. A method of treating patients who are candidates for inhaled nitric oxide treatment , which method reduces the risk that inhalation of nitric oxide gas will induce an increase in pulmonary capillary wedge pressure (PCWP) leading to pulmonary edema in neonatal patients with hypoxic respiratory failure , the method comprising:(a) performing at least one diagnostic process to identify a plurality of term or near-term neonatal patients who have hypoxic respiratory failure and are candidates for 20 ppm inhaled nitric oxide treatment, wherein the patients are not dependent on right-to-left shunting of blood;(b) determining that a first patient of the plurality does not have left ventricular dysfunction;(c) determining that a second patient of the plurality has left ventricular dysfunction, so is at particular risk of increased PCWP leading to pulmonary edema upon treatment with inhaled nitric oxide;(d) administering 20 ppm inhaled nitric oxide treatment to the first patient; and(e) excluding the second patient from treatment with inhaled nitric oxide, based on the determination that the second patient has left ventricular dysfunction, so is at particular risk of increased PCWP leading to pulmonary edema upon treatment with inhaled nitric oxide.2. The method of claim 1 , wherein the first patient has congenital heart disease.3. The method of claim 1 , wherein the left ventricular dysfunction of the second patient is attributable to congenital heart disease.4. The method of claim 1 , wherein the second patient is determined to be at particular risk not only of increased PCWP leading to pulmonary edema claim 1 , but also of other serious adverse events claim 1 , upon treatment with inhaled nitric oxide claim 1 , and the second patient is excluded from inhaled ...

Подробнее
Номер записи: 39
04-04-2013 дата публикации

ENHANCED NITRIC OXIDE DELIVERY AND USES THEREOF

Номер: US20130084336A1
Автор: Blecher Karin, Friedman Adam, Friedman Joel, Nacharaju Parimala, Nosanchuk Joshua, Tuckman-Vernon Chaim
Принадлежит: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY

Methods and compositions are disclosed that enhance delivery of nitric oxide (NO) by combining nitric oxide releasing nanoparticles (NO-np) with exogenous glutathione (GSH), as well as therapeutic uses of the methods and compositions. 1. A method for enhancing the efficacy of nitric oxide (NO) released from NO releasing nanoparticles (NO-np) comprising combining the NO-np with exogenous glutathione (GSH) so as to enhance the efficacy of NO that is released.2. The method of claim 1 , wherein S-nitrosoglutathione (GSNO) is formed by reaction of NO with GSH.3. The method of claim 1 , wherein GSH solved in a carrier mixed with NO-np.4. The method of claim 1 , wherein GSH is encapsulated in nanoparticles (GSH-np) and mixed with NO-np.5. A method of treating a microbial infection comprising applying NO to the microbes by combining NO-np and GSH according to the method of .6. The method of Wherein the infection is a bacterial claim 5 , viral claim 5 , fungal or parasitic infection.7Staphylococcus aureusEscherichia coli, Klebsielia pneumoniae,Pseudomonas aeruginosa.. The method of claim 6 , wherein the bacteria are methicillin resistant (MRSA) claim 6 , or8. A method of promoting wound healing or hair growth claim 1 , or treating a burn in a subject comprising applying NO to the wound claim 1 , hair or burn by combining NO-np and GSH according to the method of .9. A method of promoting angiogenesis or vasodilation in a subject comprising administering NO to the subject by combining NO-np and GSH according to the method of .10. A method of treating erectile dysfunction in a subject comprising topically applying NO to the penis of the subject by combining NO-np and GSH according to the method of .11. A method of administering nitric oxide (NO) to a subject comprising administering to the subject a combination of NO releasing nanoparticles (NO-np) and exogenous glutathione according to the method of .12. The method of claim 11 , wherein the subject has a cardiovascular ...

Подробнее
Номер записи: 40
11-04-2013 дата публикации

METHOD AND DEVICE FOR SUPPLYING AT LEAST ONE MEDICAL GAS TO A PATIENT RECEIVING ARTIFICIAL RESPIRATION WITH THE AID OF A VENTILATOR

Номер: US20130087145A1
Автор: Köbrich Rainer, Ulrichskötter Hermann
Принадлежит: MAQUET VERTRIEB UND SERVICE DEUTSCHLAND GMBH

A device and method for administering at least one medical gas (NO) to a patient mechanically ventilated by means of a ventilator. The ventilator produces a constant respiratory gas flow (O/N) in a feed line. Gas pulses of the medical gas (NO) are supplied to said respiratory gas flow. The gas pulses are produced by means of at least two regulating means arranged in parallel and are fed to the line. Here, a control unit controls the regulating means such that the gas pulses introduced into the feed line show a pulse repetition with constant pulse frequency. 1. A method for administering at least one medical gas toa patient mechanically ventilated by means of a ventilator,in which a first end of a first line supplying at least respiratory gas from the ventilator, a first end of a second line discharging at least exhaled gas from the patient and a first end of a patient feed line are connected to one another via at least one connecting piece,by means of the ventilator at least in one portion of the first line a constant respiratory gas flow is produced, andin which the medical gas is introduced into the first line supplying the respiratory gas,wherein a gas source for providing the medical gas to be administered and the first line are connected via at least two regulating means arranged in parallel, wherein a connection is established between the gas source and the first line via each regulating means in the opened state,in that multiple gas pulses of the medical gas are fed successively into the first line by means of the regulating means,and in that the gas pulses introduced by the regulating means into the first line have a pulse repetition with a constant pulse frequency.2. The method according to claim 1 , wherein the respiration frequency indicates the number of breaths of the patient within a certain time unit claim 1 ,that a pulse frequency indicates the pulse repetition within the same time unit,and that the regulating means are controlled by means of a ...

Подробнее
Номер записи: 41
11-04-2013 дата публикации

WATER RECOVERY AND ACID GAS CAPTURE FROM FLUE GAS

Номер: US20130089482A1
Автор: Aichele Clint P., Heald Randall L., LATIMER Edward G., Loescher Mitchell E., Schuette George F.
Принадлежит: Phillips 66 Company

Methods for removing acid gases and recovering water from flue gas. A flue gas is introduced into a water spray tower and is cooled by direct contact with a sprayed aqueous stream to condense a portion of the water vapor in the flue gas. Acid gases present in the flue gas are absorbed into the aqueous mixture, and a chemical added to the stream facilitates conversion of absorbed acid gases. The aqueous stream leaving the spray tower is next treated to remove contaminants, such as carbonates and bicarbonates, thereby producing a cleaned aqueous stream that may be split into a stream that is cooled prior to reuse in the spray tower, as well as a stream that is fed back to the boiler. 1. A process for removing acid gases and recovering water from a flue gas , comprising:a) providing a flue gas comprising combustion products of a fuel gas, and introducing the flue gas into a water spray tower;b) adding a chemical to a first aqueous stream, and introducing the first aqueous stream into a water spray tower;c) cooling the flue gas by direct contact with the first aqueous stream in the water spray tower and condensing at least a portion of the water vapor present in the flue gas, wherein the condensed water vapor combines with the first aqueous stream to produce a second aqueous stream;d) reacting the chemical with acid gases absorbed into at least one of the first aqueous stream and second aqueous stream, thereby forming reaction products;e) removing a majority of the reaction products from the second aqueous stream, thereby producing a third aqueous stream and a waste stream;f) diverting a portion of the third aqueous stream as a make-up water stream and routing the make-up water stream to the boiler of step (a), thereby minimizing the quantity of external water supply needed for the process;g) cooling the remainder of the third aqueous stream to produce the first aqueous stream of step b).2. The method of claim 1 , wherein the chemical is selected from the group ...

Подробнее
Номер записи: 42
11-04-2013 дата публикации

KIT FOR THE TREATMENT OF ONYCHOMYCOSIS BY NITRIC OXIDE

Номер: US20130089629A1
Автор: Beijer Goeran, Midander Joergen
Принадлежит: TOPICAL PHARMA AB

A kit for the treatment of onychomycosis by nitric oxide, including: a) a pre-treatment part comprising a pharmaceutically acceptable acidifying agent in an amount sufficient to loosen up the superficial outer nail plate layer, b) a treatment part comprising a pharmaceutically acceptable nitrite and at least one polysaccharide or a NO eluting polymer in one container and ascorbic acid in another container in amounts sufficient to produce nitric oxide in an amount that reduces and/or eliminates the onychomycosis upon being mixed and c) at least two devices suitable to apply a) and b) at the treatment site and upon treatment secure that the treatment site is substantially sealed. 1. A kit for the treatment of onychomycosis by nitric oxide wherein said kit comprises;a) a pre-treatment part in a carrier comprising a pharmaceutically acceptable acidifying agent in an amount sufficient to loosen up the superficial outer nail plate layer in a carrier,b) a treatment part comprising pharmaceutically acceptable nitrite and at least one polysaccharide or a NO eluting polymer in one container and ascorbic acid in another container in amounts sufficient to produce nitric oxide (NO) in an amount that reduces and/or eliminates the onychomycosis upon being mixed andc) at least two devices suitable to apply a) and b) at the treatment site and upon treatment secure that the treatment site is substantially sealed, wherein a) and b) will be subsequently applied.2. The kit according to claim 1 , wherein said acidifying agent is selected from the group consisting of absorbic acid claim 1 , ascorbyl palmitate claim 1 , salicylic acid claim 1 , lactic acid claim 1 , citric acid claim 1 , benzoic acid and tartaric acid.3. The kit according to claim 1 , wherein said polysaccharide(s) is a hydrocolloid selected from the group consisting of starch claim 1 , agar claim 1 , agarose claim 1 , carrageenan claim 1 , alginate claim 1 , chitosan or pectins claim 1 , variants or modifications thereof ...

Подробнее
Номер записи: 43
18-04-2013 дата публикации

METHOD AND DEVICE FOR SUPPLYING AT LEAST ONE MEDICAL GAS TO A PATIENT RECEIVING ARTIFICIAL RESPIRATION WITH THE AID OF A VENTILATOR

Номер: US20130092159A1
Автор: Köbrich Rainer, Ulrichskötter Hermann
Принадлежит: MAQUET VERTRIEB UND SERVICE DEUTSCHLAND GMBH

A device and method for administering at least one medical gas (NO) to a patient mechanically ventilated by means of a ventilator. The ventilator produces a constant respiratory gas flow (O/N) in a feed line. Gas pulses of the medical gas (NO) are supplied to said respiratory gas flow. The gas pulses are produced by means of at least two regulating means arranged in parallel and are fed to the line. Here, a control unit controls the regulating means depending on at least one parameter of the respiration of the patient. 1. A method for administering at least one medical gas to a patient mechanically ventilated by means of a ventilator ,in which a first end of a first line supplying at least respiratory gas from the ventilato, a first end of a second line discharging at least exhaled gas from the patient and a first end of a patient feed line are connected to one another via at least one connecting piece,by means of the ventilator at least in one portion of the first line a respiratory gas flow is produced, andin which the medical gas is introduced into the first line supplying the respiratory gas,wherein a gas source for providing the medical gas to be administered and the first line are connected via at least two regulating means arranged in parallel, wherein a connection is established between the gas source and the first line via each regulating means in the opened state,in that multiple gas pulses of the medical gas are fed successively into the first line by means of the regulating means, and in that the gas pulses depending on at least one parameter of the respiration of the patient are fed.2. The method according to claim 1 , wherein the flow rate of the respiratory gas flow is used as a parameter for the respiration of the patient and in that the respective pulse duration of the gas pulse and/or the respective volume flow of the medcial gas during the gas pulses and/or the interval between consecutive gas pulses are controlled depending on the flow rate and/ ...

Подробнее
Номер записи: 44
18-04-2013 дата публикации

Floating dispenser

Номер: US20130092635A1
Автор: Dalland Donald, Enderson Lyle, Freeberg Paul, Johnson Jeffrey D., King Joseph A.
Принадлежит:

A floating dispenser having an external float or an internal float for supporting a cartridge or cartridges for floatingly delivering a dispersant or dispersants to a body of water with the floating dispenser having cartridges rotationally positionable with respect to one another to control the rate of dispensing while the dispenser floats in an upright condition with the floating dispenser changing its flotation orientation in response to consumption of the dispersant or dispersants in the a cartridge to thereby provide a visual alert to replace a spent cartridge with a fresh cartridge. In addition the inventions described herein permit changing the dispensing nature of the system from a multiple dispensing system to a single dispensing system without changing the floating characteristics of the floating dispensers through replacement of a dispersant in one of the cartridges with an inert or ballast material that has no effect on the water characteristics. 1. A floating dispenser comprising:a first hemispherical dispensing cartridge comprising a first hemispherical cap having a first chamber therein and a set of fluid openings therein for ingress and egress of water therethrough, said first hemispherical dispensing cartridge having a pole region and a base with the first hemispherical dispensing cartridge having a hemi lune shaped gap formed between a set of radial faces of said first hemispherical dispensing cartridge;a second dispensing cartridge having a second chamber therein, said second dispensing cartridge having a base having a set of fluid openings therein for ingress and egress of water therethrough;a flotation member;a batch of non water dissolvable materials located in said first chamber; anda water dispersible material located in the second chamber whereby the batch of non water dissolvable materials in the first chamber and the water dispersible materials in the second chamber causes the center of gravity of the dispenser to be located in the second ...

Подробнее
Номер записи: 45
25-04-2013 дата публикации

Method and Device for Supplying at Least One Medical Gas to a Patient Receiving Artificial Respiration with the Aid of a Ventilator

Номер: US20130098361A1
Автор: Joost Thilo, Köbrich Rainer
Принадлежит: MAQUET VERTRIEB UND SERVICE DEUTSCHLAND GMBH

A device and method for administering at least one medical gas (NO) to a patient mechanically ventilated by means of a ventilator. The ventilator produces a respiratory gas flow (O/N) in a feed line. Gas pulses of the medical gas (NO) are supplied to said respiratory gas flow. The gas pulses are produced and fed into a patient feed line by means of at least two regulating means arranged in parallel. Firstly, the temporal start of at least one future inhalation phase of the patient is determined. Subsequently, the regulating means are controlled by means of a control unit such that a gas pulse is fed into the patient feed line at the determined start of the future inhalation phase. To achieve that the therapy gas is fed into without delay in case of very short inhalation times either nitrogen (N) or helium (He) is used as carrier gas for the active substance (NO). 1. A method for administering at least one medical gas to a patient mechanically ventilated by means of a ventilator ,in which a first end of a first line supplying at least respiratory gas from the ventilator, a first end of a second line discharging at least exhaled gas from the patient and a first end of a patient feed line are connected to one another via at least one connecting piece, andin which the medical gas is introduced into the patient feed line,wherein a gas source for providing the medical gas to be administered and the patient feed line are connected via at least two regulating means arranged in parallel, wherein a connection is established between the gas source and the patient feed line via each regulating means in the opened state,in that multiple gas pulses of the medical gas are fed successively into the patient feed line by means of the regulating means,in that the temporal start of at least one inhalation phase is determined, andin that the regulating means are controlled by means of a control unit such that a gas pulse is fed into the patient feed line at the determined start of the ...

Подробнее
Номер записи: 46
02-05-2013 дата публикации

Method and Device for Supplying at Least One Medical Gas to a Patient Receiving Artificial Respiration with the Aid of an Anesthesia Machine

Номер: US20130104885A1
Автор: Joost Thilo, Köbrich Rainer
Принадлежит: MAQUET VERTRIEB UND SERVICE DEUTSCHLAND GMBH

A device and method for administering at least one medical gas (NO) to a patient anesthetized and mechanically ventilated by means of an anesthesia machine. The anesthesia machine produces a respiratory gas flow (O/N) in a feed line. Gas pulses of the medical gas (NO) are supplied to said respiratory gas flow. The gas pulses are produced and fed into a patient feed line by means of at least two regulating means arranged in parallel. Firstly, the temporal start of at least one future inhalation phase of the patient is determined. Subsequently, the regulating means are controlled by means of a control unit such that a gas pulse is fed into the patient feed line at the determined start of the future inhalation phase. 1. A method for administering at least one medical gas to a patient anesthetized and mechanically ventilated by means of an anesthesia machine ,in which a first end of a first line supplying at least respiratory gas from the anesthesia machine, a first end of a second line discharging at least exhaled gas from the patient and a first end of a patient feed line are connected to one another via at least one connecting piece, andin which the medical gas is introduced into the patient feed line,wherein a gas source for providing the medical gas to be administered and the patient feed line are connected via at least two regulating means arranged in parallel, wherein a connection is established between the gas source and the patient feed line via each regulating means in the opened state,in that a second end of the first line and a second end of the second line are connected to one another, forming a closed circuit,in that multiple gas pulses of the medical gas are fed successively into the patient feed line by means of the regulating means,in that the temporal start of at least one inhalation phase is determined, andin that the regulating means are controlled by means of a control unit such that a gas pulse is fed into the patient feed line at the determined ...

Подробнее
Номер записи: 47
02-05-2013 дата публикации

High Flow Therapy Device Utilizing A Non-Sealing Respiratory Interface and Related Methods

Номер: US20130104888A1
Автор: Collazo Louis Javier, Landis Robert M., Lewis Charles A.
Принадлежит: MERGENET MEDICAL, INC.

A high flow therapy system for delivering pressurized, heated and humidified respiratory gas to an airway of a patient includes a respiratory gas flow pathway for delivering the pressurized respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the pressurized respiratory gas is controlled by a microprocessor, a mixing area for mixing oxygen and air in the respiratory gas flow pathway, a humidification area for humidifying respiratory gas in the respiratory gas flow pathway, a heated delivery conduit for minimizing condensation of humidified respiratory gas, a pressure pathway for monitoring pressure of the airway of the patient and communicating the monitored pressure to the microprocessor and a sensor disposed in communication with the pressure pathway, the sensor further disposed in communication with the microprocessor and configured to measure pressure in the airway of the patient. 1. A high flow therapy system for delivering pressurized , heated and humidified respiratory gas to an airway of a patient , the system comprising:a respiratory gas flow pathway for delivering the pressurized respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the pressurized respiratory gas is controlled by a microprocessor;a mixing area for mixing oxygen and air in the respiratory gas flow pathway;a humidification area for humidifying respiratory gas in the respiratory gas flow pathway;a heated delivery conduit for minimizing condensation of humidified respiratory gas;a pressure pathway for monitoring pressure of the airway of the patient and communicating the monitored pressure to the microprocessor; and,a sensor disposed in communication with the pressure pathway, the sensor further disposed in communication with the microprocessor and configured to measure pressure in the airway of the patient.2. The high flow therapy system of claim 1 , wherein at least one of ...

Подробнее
Номер записи: 48
02-05-2013 дата публикации

METHOD OF TREATING SINUSITIS, INCLUDING CHRONIC SINUSITIS

Номер: US20130108714A1
Автор: Alliger Howard M.
Принадлежит: SINOX PHARMA, INC.

The present invention relates to a method for treating acute and chronic sinusitis, and in particular, severe chronic sinusitis by exposing affected tissue of the sinus and contiguous tissue in the, nasal cavity and greater oral cavity to effective amounts of chlorine dioxide as a bioactive agent. Compositions and methods of treatment are disclosed herein. 1. A method of treating inhibiting or reducing the likelihood of sinusitis in a patient or subject comprising administering to said patient or subject a composition comprising an effective amount of chlorine dioxide.2. The method according to wherein said composition comprises about 1 ppm to about 50 ppm chlorine dioxide.3. The method according to wherein said composition comprises about 5 ppm to about 30 ppm chlorine dioxide.4. (canceled)5. The method according to wherein said composition is administered to said patient or subject by exposing membranes of the sinus claim 1 , nasal cavity and upper mouth to said composition.6. The method according to wherein said composition has a pH ranging from about 4.0 to about 6.5.7. The method according to wherein said composition is adapted for oral administration by gargling.8. The method according to wherein said composition is adapted for nasal administration.9. The method according to wherein said composition is adapted for use as a nasal spray.10. The method according to wherein said composition is adapted for use as a nasal inhaler.11. The method according to wherein said composition is adapted for use as a nasal lavage.12. The method according to wherein said composition is adapted for use as an aerosol.13. The method according to wherein said composition is adapted for use in a humidifier or steam inhaler.14. The method according to wherein said composition further comprises at least one agent selected from the group consisting of flavoring agents claim 1 , wetting agents claim 1 , mucus loosening agents claim 1 , membrane coating agents claim 1 , decongestants and ...

Подробнее
Номер записи: 49
02-05-2013 дата публикации

Therapeutic Agent and Therapeutic Device for Alleviating Ischemia-Reperfusion Injury

Номер: US20130108715A1
Автор: Kobayashi Hirosuke, Kokubo Kenichi, Shimbo Toshihiro
Принадлежит: SCHOOL JURIDICAL PERSON KITASATO INSTITUTE

Treatment for alleviating ischemia-reperfusion injury which has minimized risk of side effects and which can suppress neutrophilic infiltration and activation of platelets during ischemia reperfusion comprises administration by inhalation of a mixed gas comprising 21%-98% oxygen, 0.1%-4% hydrogen, 40-80 ppm nitrogen monoxide, and a remainder of inert gas such as nitrogen or helium to a patient undergoing reperfusion from immediately before the start of ischemia reperfusion until shortly after the start of reperfusion. 15-. (canceled)6. A gaseous inhalation pharmaceutical composition for alleviating ischemia-reperfusion injury consisting essentially of oxygen , hydrogen , nitrogen monoxide , and an inert gas.7. The composition according to claim 6 , wherein the gaseous pharmaceutical composition includes about 21% to about 98% oxygen claim 6 , about 0.1% to about 4% hydrogen claim 6 , about 40 ppm-about 80 ppm nitrogen monoxide claim 6 , and an inert gas.8. The composition according to claim 7 , wherein the gaseous pharmaceutical composition includes about 21% to about 30% oxygen claim 7 , about 2% hydrogen claim 7 , about 60-80 ppm of nitrogen monoxide claim 7 , and an inert gas.9. The composition according to claim 6 , wherein the inert gas is nitrogen.10. The composition according to claim 6 , wherein the inert gas is helium.11. An apparatus for delivering a gaseous inhalation pharmaceutical composition to an organism comprising:at least one pressure regulator;at least one flow meter in gaseous communication with the at least one pressure regulator;a plurality of gas cylinders in gaseous communication with the at least one pressure regulator; andat least one mixing device is gaseous communication with the at least one flow meter, the at least one mixing device configured to mix gas provided by the plurality of gas cylinders to produce a mixed gas.12. The apparatus according to claim 11 , further comprising:at least one valve in gaseous communication with the at ...

Подробнее
Номер записи: 50
02-05-2013 дата публикации

NASAL MASK

Номер: US20130109992A1
Автор: Guyette Robert F.
Принадлежит:

A surgical mask for use in dental procedures, and oral or facial surgery, formed of a continuous sheet of flexible material comprising a nose-conforming shell incorporating adhesive material for sealing and for maintaining position on the patient during the dental or surgical procedure. The mask forms an encasement for input/output manifolds, and terminates in flexible flange at the columella-labial junction; the mask includes a manifold for receiving and directing NO/Ointo the nasal vault of the patient, and for the removal of exhalant and the scavenging of gases from the work area. 1. A nasal mask for use with oral or facial surgery or dental procedures , comprising:(a) a single sheet of flexible plastic material comprising a nose-conforming shell having an interior and an exterior;(b) said nose-conforming shell including a labial flange contacting the patient in the columella-labial area, when the mask is in place, forming a flexible seal;{'sub': 2', '2, '(c) an input manifold, for connection to a source of regulated NO/Ogas mixture, encased within the interior of said mask, said input manifold including a single prong extending into a nasal vault of a patient for delivering the gas mixture to the patient; and'}(d) an exhaust manifold, for connection to a source of vacuum, encased within the interior of said mask, having openings opposite the patient's nasal aperture for collecting exhalant, and having openings communicating with the exterior of said mask in the vicinity of the patient's columella-labial area for scavenging any gas mixture that may have escaped from within the mask.2. The nasal mask of wherein a chamber is formed between the front wall of the mask and the patient's columella to provide a volume within which exhalant and any residual NO/Omay be scavenged or removed.3. A nasal mask for use with oral or facial surgery or dental procedures claim 1 , comprising:(a) a single sheet of flexible plastic material comprising a nose-conforming shell having ...

Подробнее
Номер записи: 51
09-05-2013 дата публикации

PROCESS FOR PROVIDING A FILLED CANISTER FOR AN INHALER

Номер: US20130112194A1
Автор: Berry Simon Christopher, Colombani Agnes Claude Marcelle Pierrette, Dickie Duncan Charles, Fletcher Ian Mark, Hodson Darren James, Jansen Robert Bernard, Lee Katherine Jane, Ludzik Andrew John, Page Tim
Принадлежит:

A process for filling a canister for an inhaler is provided. The canister may be filled with components of a medicament. The canister may be suitable for use in a pressurised metered dose inhaler, such as a breath-actuate inhaler. The process may include sealing the canister with air at ambient conditions. A filling device may dispense a pressurised liquid or gas into the sealed, air-filled canister through a metering valve. The pressurised liquid or gas may comprise at least a propellant. While pressure-filled canisters were previously purged with propellant immediately before sealing to remove the air, the present process may exclude the purging step. 1. A process for providing a filled canister for an inhaler , the process comprising the steps of:providing a canister, the canister comprising an enclosure suitable for containing a medicament and having an opening for receiving the medicament, and the canister being substantially filled with air at ambient conditions;sealing the opening of the air-filled canister by securing thereto at least one of a metering valve and a sealing mechanism;providing the sealed, air-filled canister to a filling device; anddispensing from the filling device a pressurised liquid or gas into the sealed, air-filled canister through at least one of the metering valve and a sealing mechanism, the pressurised liquid and/or gas comprising at least a propellant,wherein:the sealed canister is substantially devoid of propellant prior to the step of dispensing the pressurised liquid or gas; andthe sealed canister is substantially filled with at least a first proportion of propellant and a second proportion of air after the step of dispensing the pressurised liquid or gas.2. The process for providing a filled canister as claimed in claim 1 , further comprising the steps of:providing the air-filled canister to a medicament dispenser, prior to the step of sealing the opening of the air-filled canister; anddispensing from the medicament dispenser a ...

Подробнее
Номер записи: 52
16-05-2013 дата публикации

METHOD AND DEVICE USING PLASMON- RESONATING NANOPARTICLES

Номер: US20130122396A1
Автор: Christopher Phillip N., Linic Suljo
Принадлежит: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

Disclosed herein are methods and articles that include a plasmon-resonating nanostructure that employ a photo-thermal mechanism to catalyze the reduction of an oxidant. As such, the plasmon-resonating nanostructure catalyzes a redox reaction at a temperature below a predetermined activation temperature. The method can be efficiently used to catalyze the reduction of an oxidant, for example in a catalytic reactor or in a fuel cell that includes a photon source. 1. A method comprising:supplying an oxidant having a π-antibonding orbital to a surface of a plasmon-resonating nanostructure;exposing the plasmon-resonating nanostructure to photons at a wavelength sufficient to photoexcite the plasmon-resonating nanostructure; andreducing the oxidant at a rate about 1.1 to about 10,000, times the rate of reduction of the oxidant under the same conditions but in the absence of the photons.2. The method of claim 1 , wherein the step ofreducing the oxidant comprises reducing the oxidant at a temperature below a predetermined thermodynamic barrier.3. The method of claim 2 , further comprising supplying and oxidizing a reductant at the temperature below the predetermined activation temperature.4. The method of claim 3 , wherein the reductant is an alkene.5. The method of claim 4 , wherein the alkene is selected from the group consisting of ethylene claim 4 , propylene claim 4 , and butylene.6. The method of claim 3 , wherein the reductant is a material selected from the group consisting of hydrogen claim 3 , methanol claim 3 , and ammonia.7. The method of claim 1 , wherein the plasmon-resonating nanostructure is present on a support.8. The method of claim 7 , wherein the support is one of silica and alumina.9. The method of claim 1 , wherein reducing the oxidant produces an oxidation product selected from a group consisting of water claim 1 , ethylene oxide claim 1 , propylene oxide claim 1 , acrylonitrile claim 1 , propenal claim 1 , acrylic acid claim 1 , carbon dioxide claim 1 ...

Подробнее
Номер записи: 53
23-05-2013 дата публикации

COMPOSITIONS FOR IMPROVEMENT OF WOUND HEALING

Номер: US20130129837A1
Автор: Kaiser Dirk, Wannowius Klaus J.
Принадлежит: CYTOTOOLS AG

This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae HClOor ClOH, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology. 124.-. (canceled)25. An aqueous solution comprising a reactive chlorine compound selected from the group consisting of dichloric acids of formula HClO , derivatives thereof , anions thereof , salts thereof , and mixtures thereof.27. The aqueous solution according to claim 25 , wherein the total concentration of reactive chlorine compound is at least 0.01 M.28. The aqueous solution according to claim 25 , wherein the total concentration of reactive chlorine compound is about 0.05 M to about 1 M.29. The aqueous solution according to claim 25 , wherein the total concentration of reactive chlorine compound is about 1 mM to about 5 mM.30. The aqueous solution according to claim 25 , wherein the total concentration of reactive chlorine compound is about 0.5 mM to about 5 mM.31. The aqueous solution according to claim 25 , comprising a compound having a peak at about 189 m/z in a mass spectrum.32. The aqueous solution according to claim 31 , wherein the peak at about 189 m/z in the mass spectrum has a higher intensity than a peak at about 99 m/z in the mass spectrum.33. The aqueous solution according to claim 25 , comprising a compound having a peak at about 83.2 m/z in a mass spectrum.34. The aqueous solution according to claim 33 , wherein the peak at about 83.2 m/z in the mass spectrum has a higher intensity than a peak at about 99 m/z in the mass spectrum.35. The aqueous solution according to claim 25 , comprising a compound having a retention time of about 19.77 minutes in an ion chromatography claim 25 , wherein under the same ion chromatography conditions ...

Подробнее
Номер записи: 54
30-05-2013 дата публикации

GAS-BASED TREATMENT FOR INFECTIVE DISEASE

Номер: US20130133650A1
Автор: Drlica Karl, Zhao Xilin
Принадлежит: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY

A gas mixture for treatment of a mycobacterial infection and methods thereof, wherein the gas mixture comprises hydrogen. In certain applications, the gas mixture further comprises oxygen and optionally an inert or anaerobic gas, preferably selected from the group consisting of nitrogen, helium, argon, carbon dioxide, and mixtures thereof. The methods for treatment comprise direct inhalation of the gas mixture comprising hydrogen and oxygen, intubation of a patient with a double lumen endotracheal tube thereby supplying one lung with an anaerobic gas, and administration of a gas mixture comprising hydrogen and oxygen in a hyperbaric setting. Also provided is a method of sterilization of a -contaminated surface comprising administration of the hydrogen-containing gas mixture. 1. A gas mixture for treatment of a mycobacterial infection comprising hydrogen.2. The gas mixture of claim 1 , further comprising oxygen having a partial pressure of from about 0.17 to about 0.30.3. The gas mixture of claim 2 , further comprising an anaerobic gas.4. The gas mixture of claim 3 , wherein the anaerobic gas is selected from the group consisting of nitrogen claim 3 , helium claim 3 , argon claim 3 , carbon dioxide claim 3 , and mixtures thereof.5. The gas mixture of claim 3 , wherein the gas mixture at about one atmosphere of pressure comprises hydrogen in an amount of from about 0.1% to about 85% by volume.6. The gas mixture of claim 3 , wherein the gas mixture at about one atmosphere of pressure comprises hydrogen in an amount of from about 1.0% to about 83% by volume.7. The gas mixture of claim 3 , wherein the gas mixture at about one atmosphere of pressure comprises hydrogen in an amount of from about 2.5% to about 3.5% by volume or about 78% to about 80% by volume.8. A method for treatment of a mycobacterial respiratory tract infection in a patient comprising administering a gas mixture comprising hydrogen and oxygen to the respiratory tract of the patient via direct inhalation ...

Подробнее
Номер записи: 55
06-06-2013 дата публикации

Silicon Nitride Powder for Siliconnitride Phosphor, CaAlSiN3 Phosphor Using Same, Sr2Si5N8 Phosphor Using Same, (Sr, Ca)AlSiN3 Phosphor Using Same, La3Si6N11Phosphor Using Same, and Methods for Producing the Phosphors

Номер: US20130140490A1
Автор: Fujinaga Masataka, Jida Shinsuke, Sakai Takuma, Ueda Takayuki
Принадлежит: UBE INDUSTRIES, LTD.

Provided are: a silicon nitride powder for siliconitride phosphors with higher luminance, which can be used for a fluorescent display tube (VFD), a field emission display (FED), a plasma display panel (PDP), a cathode ray tube (CRT), a light emitting diode (LED), and the like; a CaAlSiNphosphor, an SrSiNphosphor, an (Sr, Ca)AlSiNphosphor and an LaSiNphosphor, each using the silicon nitride powder; and methods for producing the phosphors. The present invention relates to a silicon nitride powder for siliconitride phosphors, which is characterized by being a crystalline silicon nitride powder that is used as a starting material for producing a siliconitride phosphor that includes silicon element and nitrogen element but does not contain oxygen element as a constitutent element, and which is characterized by having an oxygen content of 0.2% by weight to 0.9% by weight; a CaAlSiNphosphor, an SrSiNphosphor, an (Sr, Ca)AlSiNphosphor and an LaSiNphosphor, each using the silicon nitride powder; and methods for producing the phosphors. 112-. (canceled)13. A crystalline silicon nitride powder for siliconitride phosphors , which is used as a raw material for producing a siliconitride phosphor comprising a silicon element and a nitrogen element but no oxygen element as a constituent element , an oxygen content of said silicon nitride powder being 0.2% by weight to 0.8% by weight.14. The silicon nitride powder for the siliconitride phosphors according to claim 13 , wherein the silicon nitride powder has an average particle diameter of 1.0 μm to 12 μm.15. The silicon nitride powder for the siliconitride phosphors according to claim 13 , wherein the silicon nitride powder has a specific surface area of 0.2 m/g to 4.0 m/g.16. The silicon nitride powder for the siliconitride phosphors according to claim 13 , wherein the siliconitride phosphor is a CaAlSiNphosphor claim 13 , a SrSiNphosphor claim 13 , a (Sr claim 13 , Ca)AlSiNphosphor claim 13 , or a LaSiNphosphor.17. A method for ...

Подробнее
Номер записи: 56
06-06-2013 дата публикации

HEXAGONAL BORON NITRIDE SHEET, METHOD OF PREPARING THE HEXAGONAL BORON NITRIDE SHEET, AND ELECTRONIC DEVICE INCLUDING THE HEXAGONAL BORON NITRIDE SHEET

Номер: US20130140526A1
Автор: CHOI Jae-Young, KIM Sang-Woo, SHIN Hyeon-jin
Принадлежит: SAMSUNG ELECTRONICS CO., LTD.

A hexagonal boron nitride sheet having: a two-dimensional planar structure with a spB—N covalent bond, a Van der Waals bond between boron-nitrogen layers, a root mean square surface roughness of about 2 nanometers or less, and a length of about 1 millimeter or greater. 1. A hexagonal boron nitride sheet having:{'sup': '2', 'a two-dimensional planar structure with a spB—N covalent bond;'}a Van der Waals bond between boron-nitrogen layers;a root mean square surface roughness of about 2 nanometers or less; anda length of about 1 millimeter or greater.2. The hexagonal boron nitride sheet of claim 1 , wherein the hexagonal boron nitride sheet comprises from 1 to about 100 boron-nitrogen layers.3. The hexagonal boron nitride sheet of claim 1 , wherein the hexagonal boron nitride sheet comprises hexagonal boron nitride with a purity of about 70% or greater claim 1 , when determined by Raman spectroscopy.4. The hexagonal boron nitride sheet of claim 1 , wherein the hexagonal boron nitride sheet has a peak at 1 claim 1 ,367 inverse centimeters with a full width at half maximum of about 17.0 inverse centimeters or less in a Raman spectrum.5. A method of preparing a hexagonal boron nitride sheet claim 1 , the method comprising:preparing a metal catalyst in sheet form;first thermally treating the metal catalyst to increase a grain size of the metal catalyst; andsecond thermally treating and contacting the first thermally treated metal catalyst with a nitrogen source and a boron source to form the hexagonal boron nitride sheet.6. The method of claim 5 , wherein a mean grain area of the metal catalyst in sheet form after the first thermal treatment has a mean increase of about at least 100% or greater than a mean grain area of the metal catalyst before the first thermal treatment.7. The method of claim 5 , wherein the metal catalyst in sheet form after the first thermal treatment has a mean grain area of about 1 square micrometer or greater.8. The method of claim 5 , wherein the ...

Подробнее
Номер записи: 57
06-06-2013 дата публикации

MEDICAL FOOD FOR THE DIETARY MANAGEMENT OF DEPRESSION AND ANXIETY AND METHODS THEREOF

Номер: US20130142883A1
Автор: Chernopyatko Anton Sergeevich, Pomytkin Igor Anatolyevich
Принадлежит:

A medical food for the dietary management of depression and/or anxiety includes water containing from 0.0002 to 0.0278 mol. % of isotopologue HOD, preferably, from 0.0178 to 0.0278 mol. % of isotopologue HOD. Further, a method for the dietary management of depression and/or anxiety uses the step of administering to a subject in need thereof the medical food. Further, a method of the treatment of depression includes the steps of administering to a subject an antidepressant drug and administering to the subject the medical food. Further, a method of the treatment of anxiety includes the steps of administering to a subject an antianxiety drug and administering to the subject the medical food. 1. A medical food for the dietary management of depression and/or anxiety comprising a water containing from 0.0002 to 0.0278 molecular % of isotopologue HOD.2. The medical food of claim 1 , wherein the water contains from 0.0178 to 0.0278 molecular % of isotopologue HOD.3. A method of the dietary management of depression and/or anxiety comprising a step of administering to a subject in need thereof the medical food of .4. A method of the treatment of depression in a subject in need thereof comprising steps of: (a) administering to the subject an antidepressant drug claim 1 , and (b) administering to the subject the medical food of .5. A method of the treatment of anxiety in a subject in need thereof comprising steps of: (a) administering to the subject an antianxiety drug claim 1 , and (b) administering to the subject the medical food of . The present invention is in the field of food industry and healthcare. More specifically, the present invention relates to medical foods for the dietary management of depression and anxiety.Depression is a disorder characterized by a combination of symptoms such as lowered mood, loss of energy, loss of interest, feeling of physical illness, poor concentration, altered appetite, altered sleep and a slowing down of physical and mental functions ...

Подробнее
Номер записи: 58
06-06-2013 дата публикации

Cream for Applying on a Body

Номер: US20130142884A1
Автор: Gann David L., Gann Martine, Lo Shui Yin
Принадлежит: D & Y Laboratories

A cream has at least two components, one of the components includes stable water clusters, and the cream is applied on a body to produce local surface effects, local deep effects, and non-local effects in the body. 1. A cream for applying on a body , comprising at least one first component including stable water clusters.2. A cream as defined in claim 1 , wherein said at least one first component includes the stable water clusters formed as double-helix water clusters.3. A cream as defined in claim 1 , wherein said at least one first component includes pure water and water which contains the stable water clusters.4. A cream as defined in claim 1 , further comprising at least one second component mixed with said at least one first component.5. A cream as defined in claim 4 , wherein said at least one second component is an organic component.6. A cream as defined in claim 4 , wherein said at least one second component includes an ingredient selected from the group consisting of a plant ingredient claim 4 , an animal ingredient claim 4 , a nutrient supplement ingredient claim 4 , and combination thereof.7. A cream as defined in claim 6 , wherein said plant ingredient of said at least one second component includes oil.8. A cream as defined in claim 6 , wherein said animal ingredient of said at least one second component includes beewax.9. A cream as defined in claim 6 , wherein said nutrient supplement ingredient of said at least one second component includes vitamin.10. A cream as defined in claim 3 , wherein said water with stable water clusters has a weight of substantially not more than 40% of a weight of the cream.11. A method of health enhancing claim 3 , comprising the step of applying on a body a cream which has at least one component including stable water clusters.12. A method as defined in claim 1 , wherein said applying includes applying the cream which has at least one component including stable water clusters claim 1 , on a skin of the body.13. A method as ...

Подробнее
Номер записи: 59
06-06-2013 дата публикации

System and Method for Guidance of Anesthesia, Analgesia and Amnesia

Номер: US20130144183A1
Автор: JOHN Erwin R., PRICHEP Leslie S.
Принадлежит: New York University

Method for determining anesthesia dosage includes following steps. First Interventional Agent (“FIA”) is administered to Patient at a first rate to achieve First Predetermined Plane of Anesthesia (“FPPA”). Brain waves of Patient are analyzed to formulate First Set of Data (“FSD”) corresponding to a self-norm during administration of FIA. First transfer function corresponding to patient biochemical reactions to FIA is computed from FSD. Rate of administration of FIA to Patient is altered by a selected amount after achievement of FPPA for first time required for Patient to deviate from FPPA by predetermined degree. An altered amount of FIA required to cause the predetermined deviation is determined as difference between amount of FIA that would have been delivered to Patient during first time at the first rate and an amount delivered to Patient during the first time at the altered rate. Patient is administered the altered amount of FIA. 130.-. (canceled)31. A method of determining a desired anesthesia dosage for a patient via a perturbation analysis , comprising:administering to the patient a first interventional agent at a first rate selected to achieve a first predetermined plane of anesthesia;analyzing brain waves of the patient to formulate a first set of data corresponding to a self-norm during administration of the first interventional agent;computing from the first set of data a first transfer function corresponding to patient biochemical reactions to the first interventional agent;altering the rate of administration of the first interventional agent to the patient by a selected amount after achievement of the first plane of anesthesia for a first time required for the patient to deviate from the first plane of anesthesia by a predetermined degree;determining an altered amount of the first interventional agent required to cause the predetermined deviation from the first plane of anesthesia as a difference between an amount of the first interventional agent that ...

Подробнее
Номер записи: 60
13-06-2013 дата публикации

NITROGEN FIXATION BY TITANIUM DIOXIDE

Номер: US20130149229A1
Автор: Al-Taani Ahmed A., Miller Glenn C.
Принадлежит:

In various embodiments, the present disclosure provides a method of fixing nitrogen. An amount of titania catalyst is provided and contacted with a feed stream that includes nitrogen. The titania catalyst is heated. The heated titania catalyst fixes nitrogen in the feed stream to form nitrogen products, such as nitrates. The nitrogen products are then removed from the titania catalyst. In some examples, the titania catalyst is treated with a base. In further examples, the catalytic process is carried out in the absence of light for photochemically activating the titania catalyst. 1. A nitrogen fixation method , comprising:providing an amount of titania catalyst;contacting the titania catalyst with a feed stream comprising nitrogen;heating the titania catalyst to fix nitrogen from the feed stream to form nitrogen products; andremoving the nitrogen products from the titania catalyst.2. The nitrogen fixation method of claim 1 , wherein heating the catalyst comprises heating the catalyst at a temperature of between about 40° C. and about 600° C.3. The nitrogen fixation method of claim 1 , wherein heating the catalyst comprises heating the catalyst at a temperature of between about 150° C. and about 350° C.4. The nitrogen fixation method of claim 1 , wherein heating the catalyst comprises heating the catalyst at a temperature of between about 175° C. and about 275° C.5. The nitrogen fixation method of claim 1 , further comprising treating the titania catalyst with a base.6. The nitrogen fixation method of claim 1 , wherein heating the titania catalyst is carried out at least substantially in the absence of light for photochemically activating the titania catalyst.7. The nitrogen fixation method of claim 1 , wherein heating the titania catalyst is carried out in a reactor claim 1 , the reactor being at least substantially opaque.8. The nitrogen fixation method of claim 1 , wherein heating the titania catalyst is carried out for an average time of at least about 2 hours.9. ...

Подробнее
Номер записи: 61
13-06-2013 дата публикации

Silicate Containing Compositions and Methods of Treatment

Номер: US20130149396A1
Автор: SR. Richard Thomas, Stanley, Stanley David Edward
Принадлежит: HS Pharmaceuticals, LLC

The present invention relates to compositions comprising a silicate and methods of use thereof. In particular, the compositions of the present invention are suitable for treating inflammatory conditions, cancer, bacterial and viral infections, and infected and uninfected wounds. The compositions of the present invention can also be useful in treating spinal cord injury, tissue remodeling, and promoting bone growth and repair. 123-. (canceled)24. A method of treating an infection , comprising administering to a subject in need of such treatment a composition comprising a solution with an active agent , wherein the active agent consists essentially of a silicate that liberates orthosilicic acid in vivo.25. The method of claim 24 , wherein the composition is administered parenterally claim 24 , orally claim 24 , topically claim 24 , intravenously or subcutaneously.26. The method of claim 24 , wherein the aqueous solution has a pH of about 6.0-8.0.27. The method of claim 24 , wherein the aqueous solution has a pH of about 6.5-7.8.28. The method of claim 24 , wherein the aqueous solution has a pH of 7.6.29. The method of claim 24 , wherein the active agent is present at a concentration of about 1-5 mg/mL.30. The method of claim 24 , wherein the active agent is present at a concentration of about 5 mg/mL.31. The method of claim 24 , wherein the active agent is present at a concentration of about 1-3 mg/mL.32. The method of claim 24 , wherein the active agent is present at a concentration of about 1-2 mg/mL.33. The method of claim 24 , wherein the active agent is present at a concentration of less than about 1 mg/mL.34. The method of claim 24 , wherein the active agent is present at a concentration of about 0.05-1 mg/mL.35. The method of claim 24 , wherein said administering is oral or intravenous.36. The method of claim 24 , wherein said administering is topical.37. The method of claim 24 , wherein:the solution has a pH of about 6.5-7.8; andthe active agent is present at ...

Подробнее
Номер записи: 62
20-06-2013 дата публикации

DEVICE AND SYSTEM FOR DELIVERY OF AN AEROSOL TO A PATIENT ON VENTILATORY SUPPORT

Номер: US20130152925A1
Автор: De Muynck Christian, Iwatschenko Peter, Koch Wolfgang, Pohlmann Gerhard, Rahmel Daniela, Taut Friedemann, Windt Horst
Принадлежит: TAKEDA GMBH

A device and system for delivering an aerosol to a patient on ventilatory support comprise a contact component to be positioned in contact with a respiratory organ. The contact component comprises a lumen through which breathing gas and an aerosol are delivered to lungs of a patient. 1. A device for connection of the airways of a patient on ventilatory support with a source of a breathing gas and a source of an aerosol , said device comprising one or two tubes each comprising a first lumen through which breathing gas and aerosol can be delivered to the airways of the patient;', 'a second lumen which is in fluid connection with the first lumen or lumens of the tube or the two tubes and having a longitudinal axis extending substantially perpendicularly to longitudinal axis or axes of the first lumen or lumens; and', 'a port through which aerosol can be introduced into said second lumen and arranged such that the aerosol and a breathing gas can be mixed in the second lumen;, 'a contact component adapted to be positioned in contact with the airways, the contact component comprisingthe device being characterized by a third lumen being connected to a device for generating a flow of breathing gas, wherein the second lumen is positioned proximal to, and is in fluid connection with, said third lumen.2. The device according to claim 1 , characterized in that the contact component is removably connected to a contact component holder which comprises the third lumen.3. The device according to claim 1 , characterized in that the contact component is a nasal prong.4. The device according to claim 1 , characterized in that the tube or tubes can be inserted into the patient's airways claim 1 , in particular into a nostril or both nostrils.5. The device according to claim 4 , characterized in that one of said tubes is longer than the other of said tubes.6. The device according to claim 1 , characterized in that the connection of the third lumen to the device for generating a flow of ...

Подробнее
Номер записи: 63
20-06-2013 дата публикации

PROCESS FOR REMOVING NITROUS OXIDE FROM A GAS STREAM

Номер: US20130156672A1
Автор: Angelides Christos Odyssea, Morello Bradley Douglas
Принадлежит:

A process is disclosed for the removal of nitrous oxide from a gas stream having a contaminating concentration of nitrous oxide to provide a gas stream with a significantly reduced concentration of nitrous oxide. The process includes passing the feed gas stream through a first heat transfer zone that is in heat exchange relationship with a product stream whereby heat is transferred from the product stream to the feed gas stream to thereby provide a heated gas stream; passing said heated gas stream to a reaction zone containing a NO decomposition catalyst and optionally a combination of other catalyst that provides for the decomposition of nitrous oxide or other contaminants and yielding therefrom a product stream having a reduced concentration of nitrous oxide; and passing the product stream to the first heat transfer zone to provide a cooled product stream. 1. A process for the removal of nitrous oxide (NO) from a feed gas stream containing a contaminating concentration of nitrous oxide , wherein said process comprises:(a) passing the feed gas stream through a first heat transfer zone that is in heat exchange relationship with a product stream whereby heat is transferred from the product stream to the feed gas stream to thereby provide a heated gas stream;{'sub': '2', '(b) passing said heated gas stream to a reaction zone containing a NO decomposition catalyst that provides for the decomposition of nitrous oxide and yielding therefrom a product stream having a reduced concentration of nitrous oxide; and'}(c) passing the product stream to the first heat transfer zone to provide a cooled product stream.2. A process as recited in claim 1 , further comprising passing the heated gas stream from step (a) to a second heat transfer zone whereby the heated gas stream is further heated.3. A process as recited in further comprising passing the cooled product stream to a third heat transfer zone to recover additional heat from the cooled product stream.4. A process as recited ...

Подробнее
Номер записи: 64
20-06-2013 дата публикации

AMMONIA OXIDATION/DECOMPOSITION CATALYST

Номер: US20130156687A1
Автор: Araki Sadao, Hikazudani Susumu, Mori Takuma, Taniguchi Akira
Принадлежит: HITACHI ZOSEN CORPORATION

The present invention provides an ammonia oxidation/decomposition catalyst including a support composed of an oxidizable and reducible metal oxide and a catalytically active metal supported thereon. By bringing the ammonia oxidation/decomposition catalyst including a support composed of an oxidizable and reducible metal oxide and a catalytically active metal supported thereon into contact with ammonia and air at ordinary temperature, the support in a reduced state reacts with oxygen to generate oxidation heat, and the temperature of the catalyst layer is increased in a moment. Once the temperature of the catalyst layer is increased to a temperature at which ammonia and oxygen react with each other, the ammonia oxidation reaction proceeds autonomously after that. The heat generated in this exothermic reaction is used in the course of decomposing ammonia in the presence of the catalytically active metal, thereby producing hydrogen. 2. The process for producing hydrogen according to claim 1 , wherein the metal oxide is a composite oxide.3. The process for producing hydrogen according to claim 1 , wherein the metal oxide is a rare earth metal oxide.4. The process for producing hydrogen according to claim 3 , wherein the rare earth metal oxide is cerium oxide claim 3 , lanthanum oxide claim 3 , or samarium oxide.5. The process for producing hydrogen according to claim 2 , wherein the metal oxide is a composite oxide of a rare earth metal and at least one metal selected from the group consisting of magnesium claim 2 , titanium claim 2 , zirconium claim 2 , yttrium claim 2 , aluminum claim 2 , silicon claim 2 , cobalt claim 2 , iron claim 2 , and gallium.6. The process for producing hydrogen according to claim 2 , wherein the metal oxide is a composition oxide of a rare earth metal and at least two metals selected from the group consisting of magnesium claim 2 , titanium claim 2 , zirconium claim 2 , yttrium claim 2 , aluminum claim 2 , silicon claim 2 , cobalt claim 2 , ...

Подробнее
Номер записи: 65
20-06-2013 дата публикации

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE, METHOD FOR PRODUCING SAME AND USE THEREOF

Номер: US20130156869A1
Автор: Andrade Nunes Marielza, Buck Hudson de Sousa
Принадлежит: Funddacao Arnaldo Vieira de Carvalho

The present invention provides the use of lithium compounds in micro-doses for the treatment of Alzheimer's disease. The results show that the administration of lithium in micro-doses provides a known not-toxic alternative to the elderly for slowing or stopping the progress of the disease and the progressive cognitive deterioration. 1. A pharmaceutical composition for the curative or prophylactic treatment of Alzheimer's disease characterized in that it comprisesa) a pharmaceutically acceptable carrier; andb) up to 0.28 mg daily of at least one active ingredient selected from the group comprising lithium salts or combinations thereof.2. A pharmaceutical composition according to claim 1 , comprising lithium compounds in microdoses.3. A pharmaceutical composition according to claim 1 , characterized in that said lithium salt is lithium gluconate claim 1 , lithium carbonate or combinations thereof.4. A process for the preparation of a pharmaceutical composition for the curative or prophylactic treatment of Alzheimer's disease claim 1 , comprising formulating a pharmaceutically acceptable carrier with at least one active ingredient comprising between x and y (concentration) of compounds selected from lithium claim 1 , or combinations thereof.5. The use of lithium compounds in microdoses in the preparation of medicaments for the curative or prophylactic treatment of Alzheimer's disease. The present invention relates to the field of neurology and pharmacology. More specifically, the present invention describes the use of lithium compounds, especially salts, in microdoses for the treatment of Alzheimer's disease. The results show that the administration of lithium in microdoses is a known non-toxic alternative to the elderly for slowing or stopping the progress of the disease and the progressive cognitive deterioration, acting as an inhibitor of the enzyme GSK3β.Alzheimer's disease (AD) is a neurodegenerative disease of great socioeconomic impact, accounting for about 50- ...

Подробнее
Номер записи: 66
27-06-2013 дата публикации

SPHERICAL ALUMINUM NITRIDE POWDER

Номер: US20130164534A1
Автор: Muneoka Takatoshi, Watanabe Kazutaka
Принадлежит: TOKUYAMA CORPORATION

[Problems] 1. A spherical aluminum nitride powder having an average particle diameter of 3 to 30 μm , a sphericalness of not less than 0.75 , and an oxygen concentration which is suppressed to be not more than 1% by weight wherein , when said average particle diameter is d (μm) , the specific surface area S (m/g) satisfies the following formula (1) ,{'br': None, 'i': d', 'S', 'd+, '(1.84/)≦≦(1.84/0.5) \u2003\u2003(1)'}wherein, “d” is said average particle diameter.2. A method of producing the spherical aluminum nitride powder comprising:providing an alumina or an alumina hydrate having an average particle diameter of not more than 2 μm, a eutectic agent of an oxide, a carbonate or a halide of an alkaline earth metal that is capable of melting together with the alumina at 1200 to 1800° C., and a carbon powder;{'sub': 2', '3, 'mixing 100 parts by mass of said alumina or said alumina hydrate, 0.5 parts by mass to 50 parts by mass of said eutectic agent, and said carbon powder of such an amount that the weight ratio thereof to said alumina or said alumina hydrate (C/AlO) is from 0.38 to 0.44; and'}reductively nitrogenating said alumina or said alumina hydrate by holding said mixture in a nitrogen-containing atmosphere at a temperature of 1620 to 1800° C. for not less than 2 hours. This invention relates to an aluminum nitride powder that can be favorably used as a filler for heat radiating materials for improving heat radiating property by being filled in a resin, a grease, an adhesive or a coating material, and to a method of producing the same.The aluminum nitride has such an excellent electrically insulating property and a high thermal conductivity that it has been expected that the materials such as resin, grease, adhesive and coating material filled with a sintered product or a powder of the aluminum nitride can be used as heat radiating materials featuring a high thermal conductivity.In order to improve the thermal conductivity of the heat radiating materials, it ...

Подробнее
Номер записи: 67
04-07-2013 дата публикации

METHOD FOR CONVERTING NITROGEN (N2) INTO AMMONIA AND/OR NITRATE

Номер: US20130171053A1
Автор: AL-AMMAR Essam, Al-Ansary Hany, BA-ABBAD Mazen Abdullah
Принадлежит: KING SAUD UNIVERSITY

The present invention relates to a method for converting nitrogen (N) into nitrate and/or ammonia comprising the steps of compressing air and separating nitrogen (N) and oxygen (O) therefrom, and either reacting earth alkaline metal with oxygen to produce earth alkaline metal oxide, using the high temperatures obtained to react Nand Oto NO, converting the NO with Oto NO, followed by the reaction of NOwith water to result in HNOand NO; or reacting the nitrogen obtained with earth alkaline metal to produce earth alkaline metal nitride and reacting thereof with water to result in earth alkaline metal hydroxide and ammonia. 2. Method according to claim 1 , wherein the earth alkaline metal is in the form of powder or billets.3. Method according to claim 1 , wherein an intense light glow obtained in the reaction in step b1) is transferred to photovoltaic cells for production of electricity.4. Method according to claim 1 , wherein the NO obtained in step c1) is heat exchanged with the compressed air used in step a) claim 1 , the compressed air is then expanded in a gas turbine that turns an electrical generator.5. Method according to claim 1 , wherein step b2) is carried out at a temperature of about 600-1.000° C.6. Method according to claim 1 , wherein the earth alkaline metal hydroxides obtained in step b2) are at least partly reacted with nitric acid obtained in step c1).7. Method according to claim 1 , wherein the earth alkaline metal hydroxides obtained in step b2) are at least partly reacted with hydrochloric acid according to the following equation{'br': None, 'sub': 2', '2', '2, 'Me(OH)+2HCl→MeCl+2HO'} {'br': None, 'sub': 2', '2, 'MeCl→Me+Cl,'}, 'wherein the earth alkaline metal chloride is then heated to its melting temperature and electrolyzed'} {'br': None, 'sub': 2', '2, 'H+Cl2HCl.'}, 'wherein optionally hydrochloric acid is then prepared by reacting the chlorine gas with hydrogen gas according to the following formula8. Method according to claim 7 , wherein ...

Подробнее
Номер записи: 68
04-07-2013 дата публикации

METHOD FOR GENERATING NITRIC OXIDE

Номер: US20130171272A1
Автор: Hilbig Rainer, Koerber Achim Gerhard Rolf
Принадлежит: KONINKLIJKE PHILIPS ELECTRONICS N.V.

The present invention relates to a method for generating nitric oxide, in particular for therapeutic applications, which comprises the steps of: guiding a process gas into a reaction chamber (), wherein the process gas comprises nitrous oxide in a carrier gas in a concentration in the range of ≦2 vol-%, in particular in the range of ≧10-vol-% to ≦1 vol-%, and heating the process gas to a temperature which is sufficiently high to enable a reaction of nitrous oxide to form nitric oxide, thereby forming a gas which at least partly comprises nitric oxide. This method allows generating nitric oxide without remarkable concentrations of toxic nitrogen oxides, in particular of nitrogen dioxide. The method according to the invention is particularly suitable for therapeutic applications. 1. Method for generating nitric oxide for therapeutic applications , which comprises the steps of:{'b': '12', 'guiding a process gas into a reaction chamber (), wherein'}the process gas comprises nitrous oxide in a carrier gas in a concentration in the range of ≦2 vol-%, andheating the process gas to a temperature which is sufficiently high to enable a reaction of nitrous oxide to form nitric oxide, therebyforming a gas which at least partly comprises nitric oxide.2. Method according to claim 1 , wherein the process gas is heated to a temperature in a range of ≧1000K to ≦1500K.3. Method according to claim 1 , wherein an inert gas is used as carrier gas.4. Method according to claim 1 , wherein the water content in the process gas lies in a range of ≦1 vol-%.512. Method according to claim 1 , wherein all surfaces in the reaction chamber () are inert.612. Method according to claim 1 , wherein the pressure in the reaction chamber () during the reaction lies in a range of ≧0.1 bar to ≦20 bar.7. Method according to claim 1 , wherein the reaction time of the process gas lies in a range of ≧10 ms to ≦100 s.8. Method according to claim 1 , wherein SATP flow rates of the process gas of ≧0.01 L/min to ≦ ...

Подробнее
Номер записи: 69
04-07-2013 дата публикации

METHOD OF PRODUCING A SPHERICAL ALUMINUM NITRIDE POWDER

Номер: US20130171451A1
Автор: Muneoka Takatoshi, Watanabe Kazutaka
Принадлежит: TOKUYAMA CORPORATION

To provide a method of producing a spherical aluminum nitride powder which has a large thermal conductivity and excellent filling property, and is useful as a filler for heat-radiating materials. 1. A method of producing a spherical aluminum nitride powder , comprising:mixing 100 parts by mass of an alumina or an alumina hydrate, 0.5 to 30 parts by mass of a compound containing a rare earth metal, and 38 to 46 parts by mass of a carbon powder to obtain a mixture thereof; andreductively nitriding the alumina or the alumina hydrate by holding said mixture in a nitrogen-containing atmosphere at a temperature of 1620 to 1900° C. for not less than 2 hours.2. A spherical aluminum nitride powder comprising aluminum nitride particles which have an average particle diameter of 3 to 30 μm , a content of a rare earth metal in a range of 0.4% by weight to 28% by weight calculated as an oxide thereof , and a lattice constant of the C-axis of the aluminum nitride crystals of not less than 4.9800 Å. This invention relates to a method of producing a spherical aluminum nitride powder that can be favorably used as a filler for heat radiating materials for improving heat radiating property by being filled in a resin, a grease, an adhesive or a coating material.The aluminum nitride has an excellent electrically insulating property and a high thermal conductivity, and it has been expected that the materials such as resin, grease, adhesive and coating material filled with a sintered product thereof or a powder thereof can be used as heat radiating materials featuring a high thermal conductivity.In order to improve the thermal conductivity of the heat radiating materials, it is important to densely fill the matrix such as resin with a filler having a high thermal conductivity. For this purpose, it has been strongly urged to provide an aluminum nitride powder of a spherical shape having a particle diameter of from about several microns to about several tens of microns.The aluminum nitride ...

Подробнее
Номер записи: 70
11-07-2013 дата публикации

HUMIDIFIED GASES DELIVERY APPARATUS AND METHODS FOR CONTROLLING SAME

Номер: US20130174841A1
Автор: Harwood Jonathan David, McAuley Alastair Edwin, Sun Yi-Cheng
Принадлежит: FISHER & PAYKEL HEALTHCARE LIMITED

The invention relates to a method of determining water level in a humidifier chamber that is part of a humidified gases delivery apparatus and system. The method comprising the steps of delivering power to a heater plate, varying the power delivered to the heater plate, measuring the rate of change of temperature and determining the level of water based on the heating characteristics of the volume of water within the chamber, in particular determining the level of water within the chamber based on the rate of change of temperature and the supplied power. 1. A method of determining the water level in a humidifier chamber within a humidified gases delivery system , said method comprising the steps of:delivering power to a heater used to heat contents of the chamber,determining a temperature increase over a time period while the power is delivered,determining a level of water within the chamber based on the delivered power, the temperature increase and the time period.2. A method of determining the water level in a humidifier chamber within a humidified gases delivery system as claimed in wherein the level of water within the chamber is determined based on the rate of temperature increase and a level of the delivered power.3. A method of determining the water level in a humidifier chamber within a humidified gases delivery system as claimed in wherein the level of water within the chamber is determined from a look up table claim 1 , the look up table storing values relating temperature change over a set time period for a given level of power with the level of water within the chamber.4. A method of determining the water level in a humidifier chamber within a humidified gases delivery system as claimed in wherein the level of water within the chamber is determined by using an equation for heat energy into a substance and rearranging the equation to solve for a mass.5. A method of determining the water level in a humidifier chamber within a humidified gases delivery ...

Подробнее
Номер записи: 71
11-07-2013 дата публикации

REMOVAL OF ATMOSPHERIC POLLUTANTS FROM GAS, RELATED APPARATUS, PROCESSES AND USES THEREOF

Номер: US20130177490A1
Автор: RICHARDSON Robert George
Принадлежит:

One aspect of the invention relates to a method comprising a single-stage conversion of NO and/or NOin a first stream to one or more mineral acids and/or salts thereof by reacting with nonionic gas phase chlorine dioxide ((ClO)). Another aspect of the invention relates to a method comprising first adjusting the NO and NOconcentrations in a first stream to a molar ratio of about 1:1, and then reacting with an aqueous metal hydroxide solution (MOH). Another aspect of the invention relates to an apparatus that can be used to carry out the methods disclosed herein. The methods disclosed herein are unexpectedly efficient and cost effective, and can be applied to a stream comprising high concentration and large volume of NO and/or NO. 1. A method comprising:{'sub': 2', 'x', 'x, 'contacting a first stream comprising NO and/or NO(NO) with a second stream to convert the NOin the first stream to one or more mineral acids and/or salts thereof in a single-stage conversion, wherein{'sub': '2', 'sup': '0', 'the second stream comprises nonionic gas phase chlorine dioxide ((ClO)).'}2. The method of claim 1 , wherein the second stream comprises a mist stream claim 1 , a liquid stream or a combination thereof.3. The method of claim 1 , wherein the second stream further comprises a gas stream comprising (ClO).4. The method of claim 1 , wherein the velocity of the first stream is less than about 2 claim 1 ,500 feet per minute.5. The method of claim 4 , wherein the velocity of the first stream is less than about 1 claim 4 ,000 feet per minute.6. The method of claim 1 , wherein the contact time of the first and the second streams is about 3.0 seconds or shorter.7. The method of claim 1 , wherein the first stream is agitated before or during contact with the second stream.8. The method of claim 1 , wherein the concentration of (ClO)in the second stream is about 3 claim 1 ,000 ppmV or lower.9. The method of claim 1 , wherein the concentration of the NO in the first stream is about 10 to ...

Подробнее
Номер записи: 72
11-07-2013 дата публикации

SCAVENGER OF IN VIVO HARMFUL REACTIVE OXYGEN SPECIES AND/OR FREE RADICALS

Номер: US20130177653A1
Автор: MUROTA Wataru, OHSAWA Ikuroh, OHTA Shigeo
Принадлежит:

An object of the present invention is to provide a scavenger of in vivo harmful reactive oxygen species and/or free radicals, which is capable of effectively reducing the concentrations of in vivo reactive oxygen species and/or free radicals and exhibiting given effects such as the suppression of aging process, the prevention of geriatric or lifestyle-related disease, health promotion, and the inhibition of oxidative stress by virtue of this reduction in the concentrations of reactive oxygen species and/or free radicals. The scavenger of in vivo harmful reactive oxygen species and/or free radicals of the present invention comprises a liquid or gas comprising at least a hydrogen molecule. This medium may further comprise an oxygen molecule. Furthermore, this medium may comprise water or an aqueous solution or may be a gas. The scavenger of reactive oxygen species and/or free radicals can be used in the treatment or prevention of a disorder attributed to reactive oxygen species and/or free radicals. 133-. (canceled)34. A method of treating ischemia-reperfusion injury attributed to reactive oxygen species and/or free radicals , which comprises administering a therapeutic agent comprising a scavenger of in vivo harmful reactive oxygen and/or free radicals comprising a gas comprising a hydrogen molecule as an active ingredient to a patient.35. The method according to claim 34 , wherein the in vivo harmful reactive oxygen species and/or free radicals are hydroxyl radicals or peroxynitrite.36. The method according to claim 34 , wherein the gas comprising a hydrogen molecule comprises a mixed gas of hydrogen gas and oxygen gas.37. The method according to claim 34 , wherein the gas comprising a hydrogen molecule comprises a mixed gas of hydrogen gas claim 34 , oxygen gas claim 34 , and inert gas.38. The method according to claim 34 , wherein the gas comprising a hydrogen molecule comprises a mixed gas of hydrogen gas and air.39. The method according to claim 34 , wherein the ...

Подробнее
Номер записи: 73
11-07-2013 дата публикации

METHOD AND ARRANGEMENT FOR GENERATING OXYGEN AND NITRIC OXIDE

Номер: US20130177657A1
Автор: Hilbig Rainer, Igney Claudia Hannelore, Koerber Achim Gerhard Rolf
Принадлежит: KONINKLIJKE PHILIPS ELECTRONICS N.V.

The invention relates to a Method of generating oxygen and nitric oxide. The method comprises the steps of: guiding an oxygen comprising gas to a primary side of a dense membrane (), heating the membrane () to a temperature at which it is permeable for oxygen, creating a pressure difference between the primary side of the membrane () and a secondary side of the membrane (), wherein a stream of oxygen is generated at the secondary side of the membrane () and a stream of oxygen depleted gas is generated at the primary side of the membrane (). The method according to the invention further comprises the steps of: providing a flow of nitrous oxide comprising gas and heating the nitrous oxide comprising gas to a temperature at which nitric oxide is generated. Thereby, according to the invention, heat generated in the process of operating the membrane is used. According to the invention it is possible to generate both oxygen and nitric oxide in one device making use of several synergistic effects, thus being energy saving. 1. Method of generating a gas comprising both oxygen and nitric oxide , said method comprising the steps of:{'b': '42', 'guiding an oxygen comprising gas to a primary side of a dense membrane (), wherein the dense membrane is permeable for oxygen but non-permeable for other gases,'}{'b': '42', 'heating the membrane () to a temperature at which it is permeable for oxygen,'}{'b': 42', '42', '42', '42, 'creating a pressure difference between the primary side of the membrane () and a secondary side of the membrane (), wherein a stream of oxygen is generated at the secondary side of the membrane () and a stream of oxygen depleted gas is generated at the primary side of the membrane (),wherein said method further comprises the steps of'}providing a flow of nitrous oxide comprising gas,{'b': '42', 'heating the nitrous oxide comprising gas to a temperature at which nitric oxide is generated, thereby using heat generated in the process of operating the membrane ...

Подробнее
Номер записи: 74
18-07-2013 дата публикации

METHODS FOR REDUCING NITROGEN OXIDES EMISSIONS

Номер: US20130183219A1
Автор: FITCH Frank R., Irrgang Gene H., Korn Steve, Suchak Naresh J., Vogel Edward
Принадлежит:

A method to reduce the emission of contaminants such as nitrogen oxides from the operation of a submerged combustion vaporizer. Fuels are combusted and the combustion gases are fed to an aqueous system which heats up and vaporizes cryogenic fluids in tube bundles in the submerged combustion vaporizer. Ozone is added to the aqueous system and will react with the contaminants allowing for their removal from the aqueous system. 1. A method for removing contaminants from an aqueous system present in a submerged combustion vaporizer where combustion products from said submerged combustion vaporizer are fed into said aqueous system comprising feeding ozone into said aqueous system.2. The method as claimed in wherein said combustion products are gases.3. The method as claimed in wherein said contaminants are nitrogen oxides.4. The method as claimed in wherein said ozone is fed into said aqueous system in a stoichiometric amount based on the amount of nitrogen oxides present.5. The method as claimed in wherein said ozone is fed to said aqueous system by sparging.6. The method as claimed in wherein said ozone is mixed with water prior to feeding to said aqueous system.7. The method as claimed in wherein said mixing occurs in a venturi.8. The method as claimed in wherein said ozone is fed to said aqueous system until said aqueous system is saturated with ozone.9. The method as claimed in wherein dissolved ozone desorbs into said combustion gases.10. The method as claimed in wherein the concentration of ozone fed to said aqueous system is from about 1% to about 12% ozone in air or oxygen.11. The method as claimed in further comprising providing an external duct to allow for additional residence time between the ozone and said combustion gases.12. A method for removing contaminants arising from combustion products being fed into an aqueous system comprising feeding ozone into said aqueous system.13. The method as claimed in wherein said aqueous system is part of a submerged ...

Подробнее
Номер записи: 75
18-07-2013 дата публикации

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер: US20130183300A1
Автор: ANDRES Herbert, De Haas Sanne Lysbet, Karl Johann, Scherer Stefan, Wild Norbert
Принадлежит: Hoffmann-La Roche Inc.

The invention provides methods for identifying patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist. The invention also provides methods for monitoring a patients' response to the anti-cancer therapy. The invention also provides kits and articles of manufacture for use in the methods. 1. A method of identifying a patient who may benefit from treatment with an anti-cancer therapy comprising a VEGF antagonist , the method comprising:(a) determining an expression level of unmodified VEGF in a sample obtained from the patient, wherein a level of unmodified VEGF in the sample obtained from the patient at or above a reference level identifies that the patient may benefit from treatment with the anti-cancer therapy; and(b) informing the patient that they may benefit from anti-cancer therapy comprising a VEGF antagonist.2. A method of predicting responsiveness of a patient suffering from cancer to treatment with an anti-cancer therapy comprising a VEGF antagonist , the method comprising:(a) determining an expression level of unmodified VEGF in a sample obtained from the patient, wherein a level of unmodified VEGF in the sample obtained from the patient at or above a reference level indicates that the patient is more likely to be responsive to treatment with the anti-cancer therapy; and(b) informing the patient that they have an increased likelihood of being responsive to anti-cancer therapy comprising a VEGF antagonist.3. A method for determining the likelihood that a patient with cancer will exhibit benefit from anti-cancer therapy comprising a VEGF antagonist , the method comprising:(a) determining an expression level of unmodified VEGF in a sample obtained from the patient, wherein a level of unmodified VEGF in the sample obtained from the patient at or above a reference level indicates that the patient has increased likelihood of benefit from the anti-cancer therapy; and(b) informing the patient that they have an increased ...

Подробнее
Номер записи: 76
25-07-2013 дата публикации

System and Method of Administering a Pharmaceutical Gas to a Patient

Номер: US20130186396A1
Автор: Bathe Duncan P., Montgomery Frederick J.
Принадлежит: INO THERAPEUTICS LLC

Described are methods and systems for delivering a pharmaceutical gas to a patient. The methods and systems provide varying quantities of pharmaceutical gas delivered to the patient in two or more breaths based on the monitored respiratory rate or changes in the patient's respiratory rate. 1. A method of administering a pharmaceutical gas comprising nitric oxide to a patient , the method comprising:delivering a first quantity of the pharmaceutical gas to the patient in a first breath;monitoring the patient's respiratory rate or changes in the patient's respiratory rate;varying the quantity of pharmaceutical gas delivered to the patient in one or more subsequent breaths based on the monitored respiratory rate or changes in the patient's respiratory rate.2. The method of claim 1 , wherein the quantity delivered in the subsequent breath is greater than the first quantity in response to a decrease in the patient's breathing rate.3. The method of claim 1 , wherein the quantity delivered in the subsequent breath is less than the first quantity in response to an increase in the patient's breathing rate.4. The method of claim 1 , wherein varying the quantity of pharmaceutical gas delivered to the patient avoids high unsafe doses or doses too low to be effective.5. The method of claim 1 , wherein the pharmaceutical gas is delivered to the patient every breath.6. The method of claim 1 , wherein one or more of the first quantity and the quantity delivered in the subsequent breath is delivered during the first half of inspiration.7. A nitric oxide delivery system comprising:an inlet to connect to a source of pharmaceutical gas comprising nitric oxide;an outlet to connect to a device that introduces the pharmaceutical gas to a patient;a breath trigger sensor to measure a patient's respiratory rate; anda gas control system in communication with the breath trigger sensor that delivers a varying quantity of pharmaceutical gas to the patient based on changes in the patient's ...

Подробнее
Номер записи: 77
25-07-2013 дата публикации

VENTILATOR RESPIRATORY VARIABLE-SIZED GAS ACCUMULATOR

Номер: US20130186397A1
Автор: Patel Nirav
Принадлежит: COVIDIEN LP

This disclosure describes systems and methods for ventilating a patient with a system that includes an accumulator for storing a gas mixture. The disclosure further describes a novel approach for a fast delivery of a change in gas mixture to a patient by utilizing a variable-sized accumulator. 120.-. (canceled)21. A medical ventilator system , comprising:a processor;a plurality of sources of different gases controlled by the processor;a gas manifold connected to an outlet to a patient circuit via a flow path, the gas manifold receiving gas from the plurality of gas sources forming a gas mixture;an accumulator with a plurality of chambers, the accumulator is adapted to receive the gas mixture from the gas manifold;at least one purge valve in at least one chamber of the accumulator other than a first chamber controlled by the processor, the at least one purge valve is adapted to control a release of the gas mixture from the at least one chamber other than the first chamber of the accumulator to an environment external to the patient circuit; andat least one valve controlled by the processor, the at least one valve is adapted to change a volume of the accumulator by controlling at least one chamber flow path between the plurality of chambers of the accumulator.22. The medical ventilator system of claim 21 , wherein the accumulator is positioned away from the flow path.23. The medical ventilator system of claim 22 , wherein the accumulator is positioned within the ventilator system adjacent to the flow path and the manifold.24. The medical ventilator system of claim 21 , wherein a pressure of the gas mixture in the accumulator is maintained from about 14 PSIG to 9 PSIG during a change in volume of the accumulator.25. The medical ventilator system of claim 21 , wherein the pressure of the gas mixture in the accumulator is controlled by controlling a flow rate of the gas mixture.26. The medical ventilator system of claim 21 , wherein the processor is adapted to control ...

Подробнее
Номер записи: 78
25-07-2013 дата публикации

AUTOREGULATION MONITORING

Номер: US20130190632A1
Автор: Baruch Robert A., Brady Ken M., Easley Ronald B., Rusin Craig G.
Принадлежит:

A method may include controlling a ventilator to introduce mean airway pressure (MAP) variations in a patient to induce slow waves of substantially fixed amplitude and period to the patient. The method may also include analyzing arterial blood pressure in the patient with respect to the MAP variations and determining, based on the analyzing, whether an autoregulatory mechanism associated with the patient's brain is operating properly. 1. A method , comprising:controlling a ventilator to introduce mean airway pressure (MAP) variations in a patient to induce slow waves of substantially fixed amplitude and period to the patient;analyzing arterial blood pressure in the patient with respect to the MAP variations; anddetermining, based on the analyzing, whether an autoregulatory mechanism associated with the patient's brain is operating properly.2. The method of claim 1 , wherein the analyzing is performed at a frequency corresponding to a frequency of the slow waves.3. The method of claim 2 , wherein a frequency associated with the MAP variations is less than 0.1 hertz (Hz) and the analyzing is performed at the frequency of the MAP variations.4. The method of claim 2 , wherein the determining comprises:determining whether peak blood volume in the brain is phase shifted with respect to the arterial blood pressure.5. The method of claim 1 , wherein the determining comprises:comparing arterial blood pressure of the patient to intracranial pressure of the patient in a frequency domain, andidentifying a phase angle difference between the arterial blood pressure and the intracranial pressure.6. The method of claim 5 , wherein the determining further comprises:determining that the autoregulatory mechanism is functioning properly in response to identifying that the phase angle difference is within a predetermined range.7. The method of claim 1 , wherein the controlling a ventilator comprises:controlling positive end-expiratory pressure (PEEP) provided to the patient to vary PEEP ...

Подробнее
Номер записи: 79
01-08-2013 дата публикации

Apparatus and Method for Monitoring Nitric Oxide Delivery

Номер: US20130192595A1
Автор: Acker Jaron, Medicis Joseph J., Potenziano Jim, Schmidt Jeffrey, Schnitman Robert, Tolmie Craig R.
Принадлежит: INO THERAPEUTICS LLC

Described is an apparatus for monitoring nitric oxide delivery, wherein such apparatus comprises a display that provides a visual and/or numeric indication of the calculated dose of nitric oxide. Also described is a method of monitoring nitric oxide delivery, wherein the breathing gas flow rate and therapeutic gas flow rate are measured and used to determine the calculated dose of nitric oxide, which is then displayed. In some embodiments, an alert is provided when the calculated dose rises above or falls below a predetermined level or range. 1. An apparatus to deliver therapeutic gas to a patient , the apparatus comprising:a first inlet to be placed in fluid communication with a therapeutic gas supply comprising nitric oxide;a second inlet to be placed in fluid communication with a breathing gas delivery system that provides a breathing gas to the patient;a therapeutic gas injector module to be placed in fluid communication with the first inlet and the second inlet to provide a combined flow of breathing gas and therapeutic gas;an outlet in fluid communication with the therapeutic gas injector module to supply the combined flow of breathing gas and therapeutic gas to a patient;a control circuit including a first flow sensor to measure the flow of breathing gas from the breathing gas delivery system and a second flow sensor to measure flow of therapeutic gas, wherein the control circuit determines a calculated dose of nitric oxide based on the measured flow of breathing gas and either the measured flow of therapeutic gas or a known flow of therapeutic gas; anda display in communication with the control circuit that provides a visual and/or numeric indication of the calculated dose of nitric oxide.2. The apparatus of claim 1 , wherein the visual and/or numeric indication of the calculated dose of nitric oxide is provided in parts per million (ppm) and/or as a percentage of a desired delivery concentration.3. The apparatus of claim 1 , wherein the calculated dose of ...

Подробнее
Номер записи: 80
15-08-2013 дата публикации

PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF

Номер: US20130209584A1
Автор: GIORDANO Anthony, KEVIL Christopher
Принадлежит: TheraVasc Inc.

The present invention relates to pharmaceutical compositions of nitrites such as inorganic nitrites, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The pharmaceutical compositions, which can be formulated for oral administration, can provide immediate release or extended release of the nitrite ion (NO). The pharmaceutical compositions of the invention are useful, for example, for the treatment of chronic tissue ischemia, in particular peripheral artery disease (PAD). 1. A method of treating peripheral artery disease , said method comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of inorganic nitrite , or a pharmaceutically acceptable salt thereof , and a pharmaceutically acceptable excipient , wherein said pharmaceutical composition comprises from about 20 mg to about 200 mg of inorganic nitrite and is formulated as a solid dosage form for oral administration.2. The method of claim 1 , wherein administration of said pharmaceutical composition to said subject results in a plasma concentration of nitrite ion that is maintained between 0.1 μM and 5 μM for 4-14 hours.3. The method of claim 1 , wherein said method provides an improvement in pain claim 1 , walking speed claim 1 , walking distance claim 1 , or stair climbing.4. The method of claim 1 , wherein said method provides an improvement in blood pressure.5. The method of claim 1 , wherein said subject is also diabetic.6. The method of claim 5 , wherein said method further provides an improvement in flow-mediated vasodilation.7. The method of claim 1 , wherein said inorganic nitrite is NaNO claim 1 , KNO claim 1 , or arginine nitrite.8. The method of claim 7 , wherein said inorganic nitrite is NaNO.9. The method of claim 1 , wherein said pharmaceutical composition is a tablet or capsule.10. The method of claim 1 , wherein said pharmaceutical composition comprises a pharmaceutically ...

Подробнее
Номер записи: 81
22-08-2013 дата публикации

NITRIC ACID PRODUCTION

Номер: US20130216461A1
Автор: Suchak Naresh J.
Принадлежит:

A method for reducing the levels of nitrogen oxides in the tail gas from a nitric acid production process by adding ozone to the absorber column of the production process. Nitric acid formation is also intensified by adding a mixture of secondary air and oxygen to the absorber column. 1. A method for removing contaminants from a tail gas stream of a nitric acid production process wherein nitric acid is recovered from an absorber column comprising adding ozone to said absorber column.2. The method as claimed in wherein said contaminants are selected from the group consisting of nitrogen oxides.3. The method as claimed in wherein said absorber column is a multistage absorber column.4. The method as claimed in wherein said absorber column is a plate column having from 20 to 70 plates.5. The method as claimed in wherein said ozone contacts said nitrogen oxides in between said plates.6. The method as claimed in further comprising introducing oxygen into said absorber column.7. The method as claimed in wherein said ozone is introduced into a final stage of said absorber column.8. The method as claimed in wherein said ozone is raised to the pressure of said absorber column.9. A method for removing contaminants from a tail gas stream of a nitric acid production process wherein nitric acid is recovered from an absorber column comprising feeding a process gas stream and an enhanced oxygen-containing stream into an absorber column and adding ozone to said absorber column.10. The method as claimed in wherein said contaminants are selected from the group consisting of nitrogen oxides.11. The method as claimed in wherein said absorber column is a multistage absorber column.12. The method as claimed in wherein said absorber column is a plate column having from 20 to 70 plates.13. The method as claimed in wherein said ozone contacts said nitrogen oxides in between said plates.14. The method as claimed in further comprising introducing oxygen into said absorber column.15. The method ...

Подробнее
Номер записи: 82
22-08-2013 дата публикации

CATALYTIC FUEL VAPORIZER AND FUEL REFORMER ASSEMBLY

Номер: US20130216473A1
Автор: Ngan Evan, Nicole Jacques Florian
Принадлежит: International Engine Intellectual Property Company, LLC

In one embodiment, an assembly for use with a lean NOx catalyst (LNC) is described. An outer tube is coupled to the LNC. An inner tube is disposed completely inside the outer tube. The exhaust flow is split between the inner tube and the outer tube. The inner tube houses a catalytic fuel vaporizer and a catalytic fuel reformer that convert at least a portion of the injected hydrocarbons to hydrogen and carbon monoxide, and vaporized hydrocarbons for NOx reduction. 1. An assembly , comprising:an outer tube; andan inner tube disposed completely inside the outer tube,wherein exhaust flow is split between the inner tube and the outer tube, andwherein the inner tube houses a catalytic fuel reformer.2. The assembly of claim 1 , wherein the inner tube houses a catalytic fuel vaporizer and the catalytic fuel reformer claim 1 , and wherein the outer tube is coupled to one or more of the following: a lean NOx catalyst (LNC) and a lean NOx trap (LNT).3. The assembly of claim 1 , wherein the inner tube houses a catalytic fuel vaporizer and the catalytic fuel reformer.4. The assembly of claim 1 , wherein the inner tube houses a catalytic fuel vaporizer claim 1 , the catalytic fuel reformer claim 1 , a water injector claim 1 , a heat exchanger and a water-gas shift catalyst.5. The assembly of claim 3 , wherein the catalytic fuel reformer includes a first catalyst support and a second catalyst support claim 3 , wherein the first catalyst support has a monolith structure that is uniform in a direction of flow claim 3 , and wherein the second catalyst support has a modified monolith structure that is non-uniform in the direction of flow.6. The assembly of claim 1 , wherein a fuel is injected into the inner tube claim 1 , and wherein the fuel includes one or more of the following: a hydrocarbon and an oxygenate.7. The assembly of claim 6 , wherein the hydrocarbon includes one or more of the following: gasoline claim 6 , methane and diesel.8. The assembly of claim 6 , wherein the ...

Подробнее
Номер записи: 83
29-08-2013 дата публикации

Portable Medical Gas Delivery System

Номер: US20130220319A1
Автор: Levy Frank
Принадлежит:

An apparatus for producing gas for use in medical applications. The apparatus includes a compressed gas unit having at least one container of compressed gas and a solenoid valve. An adjustable pressure regulator communicably connected to the gas container, separate and distinct from the solenoid valve, is adjusted to control the pressure of the gas provided from the container to the solenoid valve. An electrical power source is connected to the solenoid valve. A pressure activated electronic switch connected to the power source is responsive to a selected amount of voluntary fingertip, pressure for opening the solenoid valve to transmit the gas therethrough to a conduit, which further transmits the gas to a destination for use or storage. 1. An apparatus for dispensing medical gas , said apparatus comprising:a portable compressed gas unit including at least one container of a compressed medical gas, a solenoid communicably connected to said container, a pressure adjustable gas regulator separate and distinct from said solenoid and communicably interconnected between said container and said solenoid for selectively adjusting the pressure of the gas provided from said container to said solenoid, a source of electrical power connected to the solenoid and a pressure activated electric switch connected to the power source and being engaged to selectively open said solenoid; anda conduit communicably attached to an outlet of said solenoid for transmitting said gas to a destination for storage or use in a medical application when said solenoid is opened by operation of said pressure activated switch.2. The apparatus of wherein said compressed gas includes at least one of carbon dioxide claim 1 , atmospheric air claim 1 , helium and oxygen.3. The apparatus of wherein said compressed gas is contained within a replaceable compressed gas cartridge.4. The apparatus of wherein said power source includes a single battery that is mounted directly on said solenoid by a battery ...

Подробнее
Номер записи: 84
29-08-2013 дата публикации

TRANSPORTABLE WATER TREATMENT SYSTEM AND CHLORINATOR

Номер: US20130220908A1
Автор: Greene III George C., Okkema Bruce M.
Принадлежит: Water Missions International

A transportable water treatment system includes: a lower cage housing a water purifying apparatus, a middle cage housing a first water storage tank, and an upper cage housing a second water storage tank. The transportable water treatment system has a footprint approximate to the area of the lower cage. A chlorinator may be used in the water purifying apparatus that includes a bowl having an inlet at the bottom and an outlet on its side. A channel is around the inlet forcing fluid to flow to the top of the channel and over its edges. A flow diverter is positioned above the inlet adapted to transfer the flow of fluid to a substantially horizontal direction. A platform is positioned within the channel being adapted to position a single chlorine tablet within the channel. The lid is adapted for holding a plurality of chlorine tablets above the platform. 1. A chlorinator comprising:a bowl having a chlorinator inlet at the bottom and a chlorinator outlet on its side;a channel around said chlorinator inlet forcing fluid to flow to the top of said channel and over its edges to exit said chlorinator outlet;a flow diverter positioned above said inlet and within said channel adapted to transfer the flow of fluid entering said inlet from a vertical direction to a substantially horizontal direction within said channel;a platform positioned within said channel having a plurality of holes and being adapted to position a single chlorine tablet within said channel; anda lid adapted for holding a plurality of chlorine tablets above said platform and for pressurizing said chlorinator.2. The chlorinator of where said lid further including a clamping device adapted to clamp said lid onto the top of said bowl; a first arm having a bracket on one end;', 'a plurality of middle arms pivotally connected to said first arm on its other end;', 'a final arm pivotally connected to the last of said middle arms at one end and having an adjustable knob pivotally connected at the other end;', 'said ...

Подробнее
Номер записи: 85
29-08-2013 дата публикации

PROCESS OF REMOVING NOx FROM FLUE GAS

Номер: US20130224095A1
Автор: EVANS MARTIN, FLETCHER RAYMOND PAUL, MO XUNHUA
Принадлежит: INTERCAT, INC.

The invention includes a process for reducing the amount of NOdischarged to atmosphere from a FCC unit, having a regenerator and a means for collecting and supporting catalyst particles. The process comprises adding a catalyst to the regenerator flue gas prior to entering the collecting means and precipitating the catalyst in the collecting means to form a catalyst bed. Ammonia or ammonia precursor is added to the flue gas prior to and/or within the collecting means. The flue gas NOis reacted with the ammonia or ammonia precursor at 200° C. to 800° C. in the presence of the catalyst bed to reduce the NOamount, and the flue gas containing a reduced amount of NOis discharged to atmosphere. The catalyst is one or more supported transition or lanthanide metal catalysts. The process can also be utilized in any combustion process. 1. A process for reducing the amount of nitrogen oxides (NO) discharged to atmosphere from a fluid catalytic cracking unit comprising a regenerator and a collecting means for collecting and supporting catalyst particles , wherein a flue gas containing NOis discharged from the regenerator and is then passed to the collecting means , said process comprising:(a) adding a catalyst to the flue gas prior to entering the collecting means;(b) precipitating the catalyst in the collecting means to form a catalyst bed in the collecting means;(c) adding ammonia or an ammonia precursor to the flue gas prior to entering the collecting means, to the flue gas within the collecting means, or both;{'sub': x', 'x, '(d) reacting NOin the flue gas with the ammonia or ammonia precursor at a temperature ranging from 200° C. to 800° C. in the presence of the catalyst bed to reduce the amount of NOin the flue gas; and'}{'sub': 'x', '(e) discharging the flue gas containing a reduced amount of NOto atmosphere,'}wherein the catalyst is one or more supported transition or lanthanide metal catalysts.2. The process of wherein the flue gas is cooled prior to entering the ...

Подробнее
Номер записи: 86
12-09-2013 дата публикации

PHARMACEUTICAL COMPOSITION COMPRISING CITRATE AND BICARBONATE SALTS, AND USE THEREOF FOR TREATING CYSTINURIA

Номер: US20130236545A1
Автор: Granier Luc-Andre, Guittet Catherine, Roussel-Maupetit Caroline
Принадлежит: ADVICENNE

A solid oral pharmaceutical composition in the form of tablets including:—a first solid oral pharmaceutical formulation in the form of at least one micro-tablet, the micro-tablet consisting of a core including at least one Krebs cycle precursor salt as active ingredient, and of a coating including at least one coating agent, and—a second oral pharmaceutical formulation in the form of at least one mini-tablet, the mini-tablet consisting of a core including at least one bicarbonate salt as active ingredient and at least one prolonged-release matrix, and of a coating including at least one coating agent. The use thereof as a medicament, in particular in the treatment and/or prevention of cystinuria. 1. Solid pharmaceutical composition for oral use in the form of tablets comprising: 'and', 'a first solid pharmaceutical formulation for oral use in the form of at least one microtablet, said microtablet being constituted by a core comprising at least one Krebs cycle precursor salt as active ingredient, and a coating comprising at least one coating agent,'}a second pharmaceutical formulation for oral use in the form of at least one mini-tablet, the mini-tablet being constituted by a core comprising at least one bicarbonate salt as active ingredient and at least one sustained-release matrix, and a coating comprising at least one coating agent.2. Composition according to claim 1 , such that it comprises from 30 to 70% of the first formulation and from 70 to 30% of the second formulation claim 1 , by weight relative to the total weight of the composition.3. Composition according to claim 1 , such that the first formulation comprises from 40% to 80% claim 1 , preferably from 50 to 70% claim 1 , by weight Krebs cycle precursor salt based on the total weight of the first formulation and such that the second formulation comprises from 40% to 80% claim 1 , preferably from 50 to 80% claim 1 , by weight bicarbonate salt based on the total weight of the second formulation.4. ...

Подробнее
Номер записи: 87
19-09-2013 дата публикации

Methods Of Administering High Concentrations Of Nitric Oxide

Номер: US20130239963A1
Автор: Brahm Goldstein, Douglas Stuart Greene
Принадлежит: INO THERAPEUTICS LLC

Described are methods of administering therapeutic gases comprising high concentrations of nitric oxide, particularly concentrations above 2,000 ppm. The therapeutic gas may be administered at a certain dosing rate, such as less than 166 micrograms of nitric oxide per second. Also described are methods of administering a therapeutic gas comprising nitric oxide to a patient, wherein a dose of nitric oxide is administered from a portable device that includes a delivery system and a mini-cylinder. Methods of intermittent administration of nitric oxide pulses are also described.

Подробнее
Номер записи: 88
19-09-2013 дата публикации

GROUP 13 NITRIDE CRYSTAL AND GROUP 13 NITRIDE CRYSTAL SUBSTRATE

Номер: US20130243680A1
Автор: Hayashi Masahiro, KIMURA Chiharu, MIYOSHI Naoya, Murakami Akishige, Sarayama Seiji, SATOH Takashi, WADA Junichi
Принадлежит: RICOH COMPANY, LITD.

A group 13 nitride crystal has a hexagonal crystal structure containing a nitrogen atom and at least one type of metal atom selected from the group consisting of B, Al, Ga, In, and Tl. The group 13 nitride crystal has a basal plane dislocation in a plurality of directions. Dislocation density of the basal plane dislocation is higher than dislocation density of a threading dislocation of a c-plane. 1. A group 13 nitride crystal having a hexagonal crystal structure containing a nitrogen atom and at least one type of metal atom selected from the group consisting of B , Al , Ga , In , and Tl , the group 13 nitride crystal comprising:a basal plane dislocation in a plurality of directions, whereindislocation density of the basal plane dislocation is higher than dislocation density of a threading dislocation of a c-plane.2. The group 13 nitride crystal according to claim 1 , further comprising:a first area provided to an inner side of a cross-section intersecting a c-axis; anda second area provided to an outside of the first area on the cross-section and having a crystal property different from that of the first area, whereinthe basal plane dislocation includes a dislocation extending in a direction from the first area to the second area.3. The group 13 nitride crystal according to claim 1 , wherein the dislocation density of the basal plane dislocation is higher than density of grain boundary on the c-plane.4. The group 13 nitride crystal according to claim 1 , wherein the density of grain boundary of a cross-section intersecting the c-plane is higher than the density of grain boundary on the c-plane.5. The group 13 nitride crystal according to claim 1 , wherein the number of grain boundaries per 1 cmon the c-plane is equal to or less than 1.6. A group 13 nitride crystal substrate comprising the group 13 nitride crystal according to . The present application claims priority to and incorporates by reference the entire contents of Japanese Patent Application No. 2012-062235 ...

Подробнее
Номер записи: 89
19-09-2013 дата публикации

ALUMINUM NITRIDE POWDER AND METHOD OF PRODUCING THE SAME

Номер: US20130244036A1
Автор: Muneoka Takatoshi, Watanabe Kazutaka
Принадлежит: TOKUYAMA CORPORATION

[Problem] To provide a method of producing aluminum nitride that has high conducting property and can be excellently filled and is useful as a filler for heat-radiating materials, and an aluminum nitride powder obtained by the same method. 1. A method of producing an aluminum nitride powder including following steps of:{'sub': 50', '50, 'preparing a powder of alumina or hydrated alumina having a primary grain size of 0.001 to 6 am as an Al source, a powder of a rare earth metal compound having an average grain size (D) in a range of 2 to 80 μm, the average grain size (D) thereof being not less than 6 times as great as the primary grain size of said Al source, and a carbon powder,'}mixing the powder of said Al source, the powder of the rare earth metal compound and the carbon powder together, and reducing and nitriding said Al source by holding the mixed powder in a nitrogen-containing atmosphere at a temperature of 1620 to 1900° C. for not less than 2 hours.2. The method of production according to claim 1 , wherein the powder of said rare earth metal element compound is used in an amount of 0.5 to 50 parts by mass and said carbon powder is used in an amount of 35 to 50 parts by mass per 100 parts by mass of said Al source.3. An aluminum nitride powder having an average grain size (D) of 6 to 280 μm claim 1 , and containing coarse particles of a grain size of not less than 5 times as great as the average grain size (D) thereof in an amount of not more than 10% calculated as volume. This invention relates to an aluminum nitride powder that can be favorably used as a filler for heat radiating materials for improving heat radiating property by being filled in a resin, a grease, an adhesive or a coating material, and to a method of producing the same.The aluminum nitride has an excellent electrically insulating property and a high thermal conductivity, and it has been expected that a materials such as resin, grease, adhesive and coating material filled with a sintered ...

Подробнее
Номер записи: 90
26-09-2013 дата публикации

TREATMENT OF DIABETES USING G-CSF AND HYPERBARIC OXYGEN

Номер: US20130251669A1
Автор: MAHARAJ Dipnarine
Принадлежит: ADVANCED NEUROREGENERATIVE THERAPIES, LLC

A method of treating endothelial cells comprising: inducing vasodilation in a patient; and administering a composition including a stem cell proliferation agent to the patient. 120-. (canceled)21. A method for causing glucose levels to trend lower in a patient having diabetes , both during and after treatment with a combination of vasodilation and stem cell proliferation comprising:exposing said patient to an agent and/or a therapy to induce vasodilation;exposing said patient to a stem cell proliferation agent; andfurther exposing said patient to an agent/or therapy to induce vasodilation;wherein said patient's blood glucose level begins trending lower subsequent to initiation of treatment and continues to trend lower after active treatment has ended.22. The method of claim 21 , where the step of exposing said patient to an agent and/or a therapy to induce vasodilation includes administering hyperbaric oxygen treatment for a period of about five consecutive days.23. The method of wherein the step of exposing said patient to a stem cell proliferation agent includes administering a granulocyte colony stimulating factor claim 21 , a derivative or isomer thereof for a period of about seven consecutive days claim 21 , in an amount effective to result in stem cell mobilization;whereby said mobilized stem cells passively migrate into the patient's bloodstream.24. The method of wherein said mobilized stem cells are pluripotent stem cells.25. The method of wherein the step of further exposing said patient to an agent and/or a therapy to induce vasodilation includes administering hyperbaric oxygen treatment for a period of about five consecutive days.26. The method of wherein the agent or therapy to induce vasodilation includes a pharmaceutical agent which promotes vasodilation claim 21 , hyperbaric oxygen therapy and a combination thereof.27. The method of wherein the stem cell proliferation agent is a granulocyte colony stimulating factor claim 21 , a derivative or isomer ...

Подробнее
Номер записи: 91
26-09-2013 дата публикации

ANGIOGENESIS REGULATING COMPOSITION AND METHOD FOR REGULATING ANGIOGENESIS

Номер: US20130251823A1
Автор: Baba Hidekazu, FUJIMORI Junya, Murata Toshinori
Принадлежит:

An angiogenesis regulating composition used to treat/prevent an angiogenic disease in a subject, that contains in an effective amount at least one of nitrate, nitrite, and a compound convertible into nitrate or nitrite after the compound is absorbed into the subject, and an angiogenesis regulation method administering to a subject a composition containing as an active ingredient at least one of nitrate, nitrite, and a compound convertible into nitrate or nitrite after the compound is absorbed into the subject, provide a composition effective in treating and preventing angiogenic diseases, that can medically control angiogenic diseases, and medically regulate angiogenesis in ophthalmologic diseases in particular, and allows treatment without inhibiting physiological neovascularization, with a limited side effect and significantly safely, and an angiogenesis regulation method using the same. 1. An angiogenesis regulation method administering to a subject a composition containing as an active ingredient at least one of nitrate , nitrite , and a compound convertible into one of nitrate and nitrite after said compound is absorbed into the subject.2. The method according to claim 1 , regulating angiogenesis by maintaining a rate ion concentration in an effective concentration range in the subject.3. The method according to claim 1 , providing a plasma concentration of nitrate ions in the subject within a range of 8 μmol/L to 1000 μmol/L. The present invention relates to a composition used to regulate angiogenesis to treat and prevent angiogenic diseases, and a method for regulating angiogenesis.Angiogenesis refers to formation of a new blood vessel branch by endothelial cell proliferation and migration and remodeling from a pre-existing blood vessel of a tissue. In recent years, the mechanism of angiogenesis has drastically been revealed by cell biological approaches. Angiogenesis is started by induced expression of VEGF (vascular endothelial growth factor) mRNA which ...

Подробнее
Номер записи: 92
03-10-2013 дата публикации

Apparatus and method for the removal of nitrogen dioxide from a flue gas stream

Номер: US20130259786A1
Автор: Erik W. BOOS, Wuyin Wang
Принадлежит: Alstom Technology AG

Disclosed herein is an apparatus comprising an absorption chamber; a flue gas stream inlet, the flue gas stream inlet being operative to dispose a flue gas stream in the absorption chamber, wherein the flue gas stream comprises nitrogen dioxide; an absorbing agent inlet, the absorbing agent inlet being operative to dispose an absorbent agent in the absorption chamber, the absorbing agent comprising an absorbing agent compound and a solvent, wherein the absorbing agent is chemically reactive with nitrogen dioxide to absorb nitrogen dioxide from the flue gas stream, forming a reaction product.

Подробнее
Номер записи: 93
03-10-2013 дата публикации

Method for Obtaining or Recovering Nitric Acid and Hydrofluoric Acid from Solutions of Stainless Steel Pickling Systems

Номер: US20130259793A1
Автор: Frithum Gerhard, Klausner Herbert, Storek Fabian, Szokol Wilfried
Принадлежит: KEY TECHNOLOGIES INDUSTRIEBAU GMBH

A method for obtaining or recovering acids, in particular nitric acid and hydrofluoric acid, from solutions and/or metal salts of these acids containing solutions, comprising the steps of: a) spray-drying the solutions at temperatures below the decomposition temperature of the acids, the requisite energy for which is introduced via a gaseous heat-transfer medium, in order to obtain dry metal salts and gaseous acids; b) absorbing the gaseous acids formed in step a); c) separating out the dry metal salts formed in step a); optionally d) roasting the dry metal salts obtained in step a) at temperatures in the range from 400 to 900° C., in order to obtain metal oxides and gaseous acids; and e) absorbing the gaseous acids formed in step d). 1. A method for obtaining or recovering acids , in particular nitric acid and hydrofluoric acid , from solutions and/or metal salts of these acids containing solutions , comprising the steps of:a) spray-drying the solutions at temperatures below the decomposition temperature of the acids, the requisite energy for which is introduced via a gaseous heat-transfer medium, in order to obtain dry metal salts and gaseous acids;b) absorbing the gaseous acids formed in step a);c) separating out the dry metal salts formed in step a); optionallyd) roasting the dry metal salts obtained in step a) at temperatures in the range from 400 to 900° C., in order to obtain metal oxides and gaseous acids; ande) absorbing the gaseous acids formed in step d).2. The method according to claim 1 , characterized in that wherein the temperature of the gaseous heat transfer medium in method step a) is in the range from 180 to 500° C.3. The method according to claim 1 , wherein the gaseous heat-transfer medium in method step a) is air.4. The method according to claim 1 , wherein the temperature in method step d) is in the range from 500 to 800° C.5. The method according to claim 1 , wherein the absorbing of the gaseous acids obtained in method steps b) or e) takes ...

Подробнее
Номер записи: 94
03-10-2013 дата публикации

NITRIC OXIDE DELIVERY DEVICES

Номер: US20130261537A1
Автор: Hofler Lajos, Koley Dipankar, Meyerhoff Mark E.
Принадлежит: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

A nitric oxide delivery device includes a housing that is permeable to nitric oxide. The surface of the housing is modified to detect surface charge or pH (e.g., due to cell adhesion). A working electrode (which is a copper-containing conductive material or a base material coated with a copper-containing conductive material) is positioned inside of the housing. A reference/counter electrode is also positioned inside of the housing, and is electrically isolated from the working electrode. A source of nitrite ions is to be contained within the housing such that it is in contact with the working electrode. 1. A nitric oxide delivery device , comprising:a housing that is permeable to nitric oxide, the housing having a surface that is modified to detect surface charge or pH;a working electrode inside of the housing, the working electrode being a copper-containing conductive material or a base material coated with a copper-containing conductive material;a reference/counter electrode inside of the housing and electrically isolated from the working electrode; anda source of nitrite ions to be contained within the housing and in contact with the working electrode.2. The nitric oxide delivery device as defined in wherein the delivery device is a single lumen catheter or a multi-lumen catheter.3. The nitric oxide delivery device as defined in wherein the housing is silicone rubber claim 1 , and wherein a wall of the housing is modified with a lipophilic cation/anionic salt and a plasticizer.4. The nitric oxide delivery device as defined in claim 1 , further comprising circuitry electrically connected to the working electrode and the reference/counter electrode to detect a shift in potential that exceeds a threshold value claim 1 , and in response to the detection claim 1 , selectively apply a voltage to the working electrode versus the reference/counter electrode.5. The nitric oxide delivery device as defined in claim 1 , further comprising:an external reference electrode ...

Подробнее
Номер записи: 95
10-10-2013 дата публикации

Fluorescent substance and method for preparing same

Номер: US20130264597A1
Автор: Bong Goo Yun, Chul Soo Yoon, Jeong Eun Yun, Tae Min Ahn, Won Young Song, Woo Jung Park, Young Ii Kim
Принадлежит: SAMSUNG ELECTRONICS CO LTD

Disclosed is a method for preparing a fluorescent substance, which is represented by the formula M 1-z Eu z Si a O b N c (M=Sr 1-x-y Ba x Ca y , 0 x 0.5, 0 y 0.2, 0<z 0.3, 2 a 2.5, 1.5 b 2, and 2 c 2.5), and the present invention provides the method for preparing a nitride-based fluorescent substance comprising the following steps: a preliminary firing step further comprising a first firing step of creating a first firing product by mixing and firing a first precursor group including an M precursor and a first silicon precursor, and a second firing step of creating a second firing product by mixing and firing a second precursor group including an Eu precursor and a second silicon precursor; and a secondary firing step of mixing and firing the first firing product and the second firing product.

Подробнее
Номер записи: 96
10-10-2013 дата публикации

MAPK INHIBITION BY H2

Номер: US20130266540A1
Автор: Kajiya Mikihito, Kawai Toshihisa, SATO Kimihiro
Принадлежит:

A method of treating and protecting a subject from endotoxin shock by administering a composition including hydrogen, releasing hydrogen in the subject, and down-regulating production of TNF-α and IL-6. A method of treating inflammation in a subject. A method of suppressing hydroxyl radical in a subject. A method of treating inflammation in a subject. A method of reducing the basal level of phosphorylation of MAPKs in non-stimulated monocyte lineage cells in a subject. Methods of performing drug screen tests for compounds that can treat the above conditions. A diagnostic method for diagnosing patients with diseases caused by the MAPK pathway. 1. A method of treating and protecting a subject from endotoxin shock , including the steps of:administering a composition including hydrogen;releasing hydrogen in the subject; anddown-regulating production of TNF-α and IL-6.2. The method of claim 1 , wherein the composition is neutral ionized water.3. The method of claim 2 , wherein the neutral ionized water is in a dosage form chosen from the group consisting of a drink claim 2 , a topical solution claim 2 , and an injection.4. The method of claim 2 , wherein the neutral ionized water is a neutraceutical.5. The method of claim 1 , wherein the composition is chosen from the group consisting of water that is directly dissolved with hydrogen gas claim 1 , a bacterium producing hydrogen claim 1 , metal claim 1 , and alloys.6. A method of treating inflammation in a subject claim 1 , including the steps of:administering a composition including hydrogen;releasing hydrogen in the subject; anddown-regulating inflammatory responses of monocyte lineage cells.7. The method of claim 6 , wherein said down-regulating step is further defined as down-regulating TNF-α claim 6 , IL-6 claim 6 , and IL-12p40.8. The method of claim 6 , further including the step of measuring the down-regulation of TNF-α claim 6 , IL-6 claim 6 , and IL-12p40 and confirming that inflammation is treated.9. The method ...

Подробнее
Номер записи: 97
17-10-2013 дата публикации

SYSTEM AND METHOD OF PROVIDING FEEDBACK TO A SUBJECT RECEIVING RESPIRATORY THERAPY VIA A CLIENT DEVICE ASSOCIATED WITH THE SUBJECT

Номер: US20130269700A1
Автор: "OConnor Nathan Francis", Laura Lapoint Manuel
Принадлежит: KONINKLIJKE PHILIPS ELECTRONICS N.V.

Feedback information is provided to a subject regarding reception of pressure support therapy, and/or other respiratory support therapy. The feedback information may indicate compliance to a respiratory therapy regimen. The feedback information is provided to the subject by transmitting the feedback information through a communication network to a client device associated with the subject. The feedback information may include a characterization of the therapy received by the subject with respect to a usage goal. 1. A system configured to provide feedback to a subject regarding compliance to a respiratory therapy regimen , the system comprising:{'b': '20', 'claim-text': [{'b': '38', 'a usage module () configured to monitor usage of a pressure support device configured to deliver a pressurized flow of breathable gas to the airway of the subject in accordance with the therapy regimen, wherein usage of the pressure support device by the subject includes receiving the pressurized flow of breathable gas into the airway; and'}, {'b': '44', 'a feedback module () configured to provide to the subject feedback information related to the usage of the pressure support device by the subject, wherein the feedback module is configured to transmit the feedback information to a client device associated with the subject through a communication network.'}], 'one or more processors () configured to implement computer program modules, the modules comprising2. The system of claim 1 , wherein the system includes a device further comprising:{'b': '28', 'the pressure support device (), which is configured to generate the pressurized flow of breathable gas for delivery to the airway of the subject; and'}{'b': '34', 'one or more sensors () configured to generate output signals that indicate whether the pressurized flow of breathable gas is being received into the airway of the subject;'}wherein the usage module is configured to monitor usage of the pressure support device based on the output ...

Подробнее
Номер записи: 98
17-10-2013 дата публикации

On Demand Generation of Ammonia for Small Industrial and Commercial Boilers

Номер: US20130272940A1
Автор: Broderick Jeffrey Michael, Broderick R. Gifford, Lindemann Scott H., Schindler Edmund S., Valentine James M.
Принадлежит:

A system and method for reducing NOx emissions from a lean burn combustion source is provided. The system includes a blower passing air through a continuous duct having a hot portion and a reaction portion. The hot portion of the duct is positioned in the convective zone of the combustion source to heat the passing air for the reaction portion of the duct. An injector attached to a urea storage container is positioned in the reaction portion of the duct and sprays urea from the storage container into the heated air in the reaction duct for evaporation and decomposition into ammonia gas. The ammonia gas is then supplied to an injection grid in the exhaust duct of the lean burn combustion source upstream of a NOx reduction catalyst. The injection grid supplies the ammonia gas to the exhaust gas in the exhaust duct. 1. A method for reducing NOx emissions from a lean burn combustion source , comprising the steps of:providing an injection grid in a primary exhaust duct of a lean burn combustion source upstream of a NOx reduction catalyst;providing a continuous duct between an air intake and the injection grid, the continuous duct having a hot portion and a reaction portion, the reaction portion connected to the injection grid;passing air from the air intake through the continuous duct, at least a portion of the hot portion of the continuous duct positioned in a convective zone of the lean burn combustion source, the hot portion of the duct having a first average cross-sectional area perpendicular to the passing air, the hot portion of the duct supplying heated air to the reaction portion, the reaction portion having a second average cross-sectional area perpendicular to the passing air;positioning at least one injector in the reaction portion;supplying an aqueous solution of urea from a storage chamber to the at least one injector;injecting the urea solution into the heated air in the reaction portion for evaporation and decomposition into ammonia gas;supplying the ...

Подробнее
Номер записи: 99
17-10-2013 дата публикации

System and method for improving outcome of cerebral ischemia

Номер: US20130273179A1
Автор: Allan Rozenberg, Axel Heinemann, Denise Barbut
Принадлежит: ASTUCE Inc

A method for improving outcome following cerebral ischemia is provided. The method includes delivering nitric oxide into the nasal cavity for absorption into the brain through the nasal vasculature and preventing the inhalation of nitric oxide into the lungs to prevent pulmonary vasodilatation.

Подробнее
Номер записи: 100